| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | type I interferon receptor binding | 2.98e-10 | 17 | 218 | 7 | GO:0005132 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | UBA5 MYH9 ATRX MCM8 MYO1E MCM5 MCM6 MCM7 ABCA10 ABCA9 ABCA8 CLU CARNS1 DNAH9 IPO8 DNAH10 DNAH2 RECQL FANCM DNAH7 MYH15 | 4.06e-06 | 614 | 218 | 21 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ATRX MCM8 MYO1E MCM5 MCM6 MCM7 ABCA10 ABCA9 ABCA8 CLU CARNS1 DNAH9 DNAH10 DNAH2 RECQL FANCM DNAH7 | 7.53e-06 | 441 | 218 | 17 | GO:0016887 |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.19e-05 | 28 | 218 | 5 | GO:0051959 | |
| GeneOntologyMolecularFunction | 3'-5' DNA helicase activity | 2.27e-05 | 16 | 218 | 4 | GO:0043138 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 3.75e-05 | 18 | 218 | 4 | GO:0008569 | |
| GeneOntologyMolecularFunction | actin filament binding | MYH9 MYO1E SPTBN1 SPTBN2 AFDN FMNL1 SYNE1 FMNL3 SPTBN4 CLMN MYH15 | 4.21e-05 | 227 | 218 | 11 | GO:0051015 |
| GeneOntologyMolecularFunction | DNA helicase activity | 5.84e-05 | 62 | 218 | 6 | GO:0003678 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | CLSTN3 MYH9 MYO1E CENPF SPTBN1 SPTBN2 PTPN3 MRTFB HOOK1 CLU SYNE2 AFDN TTLL1 FMNL1 MTUS2 GOLGA2 KPNB1 SYNE1 PTPRT CAPN10 FMNL3 SPTBN4 CLMN SBDS MYH15 CFAP157 NIN | 6.93e-05 | 1099 | 218 | 27 | GO:0008092 |
| GeneOntologyMolecularFunction | single-stranded DNA helicase activity | 1.04e-04 | 23 | 218 | 4 | GO:0017116 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | CLSTN3 MYH9 SPTBN1 SPTBN2 ADAM11 FASN MRTFB NLGN4X PTPRO AFDN VSIG10L2 GOLGA2 NLGN4Y SH3GL1 GRIN2A PTPRT CDH22 TJP1 | 1.08e-04 | 599 | 218 | 18 | GO:0050839 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 3.18e-04 | 118 | 218 | 7 | GO:0003774 | |
| GeneOntologyMolecularFunction | cadherin binding | MYH9 SPTBN1 SPTBN2 FASN MRTFB PTPRO AFDN GOLGA2 SH3GL1 PTPRT CDH22 TJP1 | 3.69e-04 | 339 | 218 | 12 | GO:0045296 |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 4.96e-04 | 127 | 218 | 7 | GO:0008094 | |
| GeneOntologyMolecularFunction | 5'-nucleotidase activity | 5.30e-04 | 15 | 218 | 3 | GO:0008253 | |
| GeneOntologyMolecularFunction | scaffold protein binding | 5.47e-04 | 93 | 218 | 6 | GO:0097110 | |
| GeneOntologyMolecularFunction | GTPase binding | SPTBN1 GIT2 TRIP11 AFDN ULK1 FMNL1 KPNB1 IPO8 SH3GL1 FMNL3 DOCK7 ACAP2 | 6.28e-04 | 360 | 218 | 12 | GO:0051020 |
| GeneOntologyMolecularFunction | neurexin family protein binding | 6.47e-04 | 16 | 218 | 3 | GO:0042043 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 6.88e-04 | 37 | 218 | 4 | GO:0045505 | |
| GeneOntologyMolecularFunction | actin binding | MYH9 MYO1E SPTBN1 SPTBN2 MRTFB HOOK1 SYNE2 AFDN FMNL1 SYNE1 FMNL3 SPTBN4 CLMN MYH15 | 8.28e-04 | 479 | 218 | 14 | GO:0003779 |
| GeneOntologyMolecularFunction | nucleotidase activity | 9.28e-04 | 18 | 218 | 3 | GO:0008252 | |
| GeneOntologyMolecularFunction | cytoskeleton-nuclear membrane anchor activity | 1.16e-03 | 5 | 218 | 2 | GO:0140444 | |
| GeneOntologyMolecularFunction | protein-membrane adaptor activity | 1.45e-03 | 45 | 218 | 4 | GO:0043495 | |
| GeneOntologyMolecularFunction | MAP kinase kinase kinase kinase activity | 1.73e-03 | 6 | 218 | 2 | GO:0008349 | |
| GeneOntologyMolecularFunction | four-way junction helicase activity | 1.73e-03 | 6 | 218 | 2 | GO:0009378 | |
| GeneOntologyMolecularFunction | cytokine activity | 1.76e-03 | 250 | 218 | 9 | GO:0005125 | |
| GeneOntologyMolecularFunction | helicase activity | 1.78e-03 | 158 | 218 | 7 | GO:0004386 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ATRX MCM8 MYO1E MCM5 MCM6 MCM7 ABCA10 ABCA9 ABCA8 CLU CARNS1 DNAH9 DNAH10 DNAH2 RECQL FANCM DNAH7 ARHGAP5 | 2.18e-03 | 775 | 218 | 18 | GO:0017111 |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-serine phosphorylation of STAT protein | 1.33e-09 | 21 | 217 | 7 | GO:0033141 | |
| GeneOntologyBiologicalProcess | regulation of peptidyl-serine phosphorylation of STAT protein | 3.85e-09 | 24 | 217 | 7 | GO:0033139 | |
| GeneOntologyBiologicalProcess | serine phosphorylation of STAT protein | 1.27e-08 | 28 | 217 | 7 | GO:0042501 | |
| GeneOntologyBiologicalProcess | regulation of peptidyl-serine phosphorylation | NTRK2 RICTOR IFNA4 IFNA5 IFNA7 IFNA8 IFNA10 IFNA17 IFNA21 SPTBN4 AKAP9 DOCK7 | 2.38e-08 | 137 | 217 | 12 | GO:0033135 |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-serine phosphorylation | NTRK2 IFNA4 IFNA5 IFNA7 IFNA8 IFNA10 IFNA17 IFNA21 AKAP9 DOCK7 | 1.13e-07 | 101 | 217 | 10 | GO:0033138 |
| GeneOntologyBiologicalProcess | natural killer cell activation involved in immune response | 2.56e-07 | 42 | 217 | 7 | GO:0002323 | |
| GeneOntologyBiologicalProcess | response to dsRNA | 3.11e-07 | 63 | 217 | 8 | GO:0043331 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | MYH9 ATRX INCENP CUL9 HOOK1 SYNE2 POC1B ULK4 TTLL1 GOLGA2 KPNB1 DNAH2 MEI1 DNAH7 CCDC39 AKAP9 CEP72 SBDS DOCK7 CCDC102B ANKFN1 CFAP157 CHMP1A NIN | 6.57e-07 | 720 | 217 | 24 | GO:0000226 |
| GeneOntologyBiologicalProcess | response to exogenous dsRNA | 1.71e-06 | 55 | 217 | 7 | GO:0043330 | |
| GeneOntologyBiologicalProcess | regulation of receptor signaling pathway via STAT | AKR1B1 IFNA4 IFNA5 PTPRT IFNA7 IFNA8 IFNA10 IFNA17 IFNA21 EGF | 2.85e-06 | 143 | 217 | 10 | GO:1904892 |
| GeneOntologyBiologicalProcess | brain development | GABRB3 ATRX CENPF SPTBN2 GIT2 EZH2 RYK MRTFB NLGN4X SYNE2 ULK4 AFDN TTLL1 ULK1 NLGN4Y NTRK2 GRIN2A CRH CCDC39 EGF SLIT1 DOCK7 PRDM13 PBX3 NIN | 4.34e-06 | 859 | 217 | 25 | GO:0007420 |
| GeneOntologyBiologicalProcess | head development | GABRB3 ATRX CENPF SPTBN2 GIT2 EZH2 RYK MRTFB NLGN4X SYNE2 ULK4 AFDN TTLL1 ULK1 CRISPLD1 NLGN4Y NTRK2 GRIN2A CRH CCDC39 EGF SLIT1 DOCK7 PRDM13 PBX3 NIN | 4.58e-06 | 919 | 217 | 26 | GO:0060322 |
| GeneOntologyBiologicalProcess | peptidyl-serine phosphorylation | ULK1 NTRK2 RICTOR IFNA4 IFNA5 IFNA7 IFNA8 IFNA10 IFNA17 IFNA21 SPTBN4 ULK3 AKAP9 DOCK7 | 4.99e-06 | 307 | 217 | 14 | GO:0018105 |
| GeneOntologyBiologicalProcess | regulation of receptor signaling pathway via JAK-STAT | 7.12e-06 | 125 | 217 | 9 | GO:0046425 | |
| GeneOntologyBiologicalProcess | peptidyl-serine modification | ULK1 NTRK2 RICTOR IFNA4 IFNA5 IFNA7 IFNA8 IFNA10 IFNA17 IFNA21 SPTBN4 ULK3 AKAP9 DOCK7 | 7.74e-06 | 319 | 217 | 14 | GO:0018209 |
| GeneOntologyBiologicalProcess | positive regulation of protein metabolic process | MYH9 INCENP DAPK1 EZH2 NEDD9 MALT1 CLU PIK3CG RPUSD3 FBXO33 TSACC GOLGA2 NTRK2 COP1 RICTOR GRIN2A FANCM SKP2 CRH IFNA4 IFNA5 IFNA7 FAF1 TXNDC12 IFNA8 IFNA10 IFNA17 IFNA21 EGF AKAP9 P2RX7 DOCK7 LRP4 UBR3 | 9.87e-06 | 1458 | 217 | 34 | GO:0051247 |
| GeneOntologyBiologicalProcess | microtubule-based process | MYH9 ATRX INCENP CUL9 HOOK1 SYNE2 POC1B ULK4 TTLL1 DNAH9 GOLGA2 KPNB1 DNAH10 DNAH2 MEI1 DNAH7 CCDC39 AKAP9 CEP72 SBDS AP3B2 DOCK7 CCDC102B ANKFN1 CFAP157 CHMP1A NIN | 1.91e-05 | 1058 | 217 | 27 | GO:0007017 |
| GeneOntologyBiologicalProcess | positive regulation of protein modification process | INCENP EZH2 NEDD9 MALT1 PIK3CG FBXO33 TSACC GOLGA2 NTRK2 RICTOR FANCM SKP2 CRH IFNA4 IFNA5 IFNA7 IFNA8 IFNA10 IFNA17 IFNA21 EGF AKAP9 P2RX7 DOCK7 LRP4 | 1.91e-05 | 937 | 217 | 25 | GO:0031401 |
| GeneOntologyBiologicalProcess | positive regulation of phosphorus metabolic process | MYH9 INCENP EZH2 RYK NEDD9 MALT1 PIK3CG TSACC NR1H4 NTRK2 RICTOR CRH IFNA4 IFNA5 IFNA7 IFNA8 IFNA10 IFNA17 IFNA21 EGF AKAP9 P2RX7 DOCK7 LRP4 | 1.96e-05 | 879 | 217 | 24 | GO:0010562 |
| GeneOntologyBiologicalProcess | positive regulation of phosphate metabolic process | MYH9 INCENP EZH2 RYK NEDD9 MALT1 PIK3CG TSACC NR1H4 NTRK2 RICTOR CRH IFNA4 IFNA5 IFNA7 IFNA8 IFNA10 IFNA17 IFNA21 EGF AKAP9 P2RX7 DOCK7 LRP4 | 1.96e-05 | 879 | 217 | 24 | GO:0045937 |
| GeneOntologyBiologicalProcess | premeiotic DNA replication | 2.24e-05 | 6 | 217 | 3 | GO:0006279 | |
| GeneOntologyBiologicalProcess | central nervous system development | GABRB3 ATRX CENPF SPTBN1 SPTBN2 GIT2 EZH2 RYK MRTFB NLGN4X CLU SYNE2 ULK4 AFDN TTLL1 ULK1 NLGN4Y NTRK2 SH3GL1 GRIN2A CRH CCDC39 SPTBN4 EGF SLIT1 DOCK7 PRDM13 PBX3 NIN | 2.40e-05 | 1197 | 217 | 29 | GO:0007417 |
| GeneOntologyBiologicalProcess | interferon-mediated signaling pathway | 2.46e-05 | 112 | 217 | 8 | GO:0140888 | |
| GeneOntologyBiologicalProcess | nuclear migration | 2.67e-05 | 34 | 217 | 5 | GO:0007097 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphorylation | INCENP EZH2 RYK NEDD9 MALT1 PIK3CG TSACC NTRK2 RICTOR CRH IFNA4 IFNA5 IFNA7 IFNA8 IFNA10 IFNA17 IFNA21 EGF AKAP9 P2RX7 DOCK7 LRP4 | 2.72e-05 | 780 | 217 | 22 | GO:0042327 |
| GeneOntologyBiologicalProcess | positive regulation of protein phosphorylation | INCENP EZH2 NEDD9 MALT1 PIK3CG TSACC NTRK2 RICTOR CRH IFNA4 IFNA5 IFNA7 IFNA8 IFNA10 IFNA17 IFNA21 EGF AKAP9 P2RX7 DOCK7 LRP4 | 2.78e-05 | 724 | 217 | 21 | GO:0001934 |
| GeneOntologyBiologicalProcess | type I interferon-mediated signaling pathway | 3.19e-05 | 85 | 217 | 7 | GO:0060337 | |
| GeneOntologyBiologicalProcess | cellular response to type I interferon | 3.44e-05 | 86 | 217 | 7 | GO:0071357 | |
| GeneOntologyBiologicalProcess | cell junction assembly | GABRB3 CLSTN3 MYH9 SLC39A9 SPTBN2 RYK NLGN4X PTPRO SRGAP3 AFDN NR1H4 NLGN4Y NTRK2 CDH22 TJP1 SLIT1 DOCK7 LRP4 | 3.50e-05 | 569 | 217 | 18 | GO:0034329 |
| GeneOntologyBiologicalProcess | cell junction organization | GABRB3 CLSTN3 MYH9 SLC39A9 SPTBN2 RYK NEDD9 NLGN4X PTPRO SRGAP3 AFDN NR1H4 CACNA1S NLGN4Y NTRK2 NBEA GRIN2A PTPRT SPTBN4 CDH22 TJP1 SLIT1 DOCK7 CNTNAP4 LRP4 | 3.62e-05 | 974 | 217 | 25 | GO:0034330 |
| GeneOntologyBiologicalProcess | synapse organization | GABRB3 CLSTN3 SPTBN2 RYK NEDD9 NLGN4X PTPRO SRGAP3 AFDN CACNA1S NLGN4Y NTRK2 NBEA GRIN2A PTPRT SPTBN4 SLIT1 DOCK7 CNTNAP4 LRP4 | 3.97e-05 | 685 | 217 | 20 | GO:0050808 |
| GeneOntologyBiologicalProcess | cellular response to virus | 4.62e-05 | 90 | 217 | 7 | GO:0098586 | |
| GeneOntologyBiologicalProcess | regulation of defense response to virus by host | 5.22e-05 | 63 | 217 | 6 | GO:0050691 | |
| GeneOntologyBiologicalProcess | response to type I interferon | 5.32e-05 | 92 | 217 | 7 | GO:0034340 | |
| GeneOntologyBiologicalProcess | B cell differentiation | HDAC9 EZH2 MALT1 IFNA4 IFNA5 IFNA7 IFNA8 IFNA10 IFNA17 IFNA21 | 5.57e-05 | 201 | 217 | 10 | GO:0030183 |
| GeneOntologyBiologicalProcess | postsynapse assembly | 5.70e-05 | 93 | 217 | 7 | GO:0099068 | |
| GeneOntologyBiologicalProcess | DNA unwinding involved in DNA replication | 6.20e-05 | 21 | 217 | 4 | GO:0006268 | |
| GeneOntologyBiologicalProcess | subtelomeric heterochromatin formation | 9.21e-05 | 9 | 217 | 3 | GO:0031509 | |
| GeneOntologyBiologicalProcess | nucleus localization | 9.57e-05 | 44 | 217 | 5 | GO:0051647 | |
| GeneOntologyBiologicalProcess | cell surface receptor signaling pathway via STAT | AKR1B1 IFNA4 IFNA5 PTPRT IFNA7 IFNA8 IFNA10 IFNA17 IFNA21 EGF | 1.01e-04 | 216 | 217 | 10 | GO:0097696 |
| GeneOntologyBiologicalProcess | synapse assembly | GABRB3 CLSTN3 SPTBN2 RYK NLGN4X SRGAP3 AFDN NLGN4Y NTRK2 SLIT1 DOCK7 LRP4 | 1.09e-04 | 308 | 217 | 12 | GO:0007416 |
| GeneOntologyBiologicalProcess | presynaptic membrane assembly | 1.31e-04 | 10 | 217 | 3 | GO:0097105 | |
| GeneOntologyBiologicalProcess | organelle assembly | CDS1 INCENP CENPF SPTBN2 CENPK TBC1D16 TBC1D10C FAU SYNE2 POC1B ULK4 TTLL1 ULK1 GOLGA2 KPNB1 SYNE1 DNAH2 DNAH7 CCDC39 ULK3 P2RX7 CEP72 SBDS DOCK7 CFAP157 CHMP1A | 1.68e-04 | 1138 | 217 | 26 | GO:0070925 |
| GeneOntologyBiologicalProcess | DNA duplex unwinding | 1.73e-04 | 78 | 217 | 6 | GO:0032508 | |
| GeneOntologyBiologicalProcess | T cell activation involved in immune response | 1.76e-04 | 148 | 217 | 8 | GO:0002286 | |
| GeneOntologyBiologicalProcess | postsynaptic membrane assembly | 1.78e-04 | 11 | 217 | 3 | GO:0097104 | |
| GeneOntologyBiologicalProcess | regulation of phosphorylation | INCENP MCM7 EZH2 RYK NEDD9 MALT1 PTPRO PIK3CG ULK4 TSACC NTRK2 RICTOR CRH IFNA4 IFNA5 PTPRT IFNA7 IFNA8 IFNA10 IFNA17 IFNA21 SPTBN4 EGF AKAP9 P2RX7 DOCK7 LRP4 | 2.27e-04 | 1226 | 217 | 27 | GO:0042325 |
| GeneOntologyBiologicalProcess | establishment of organelle localization | MYH9 INCENP CENPF TRIP11 PIK3CG SYNE2 KPNB1 SYNE1 MEI1 P2RX7 CLMN AP3B2 SLIT1 DOCK7 ANKFN1 CHMP1A | 2.30e-04 | 546 | 217 | 16 | GO:0051656 |
| GeneOntologyBiologicalProcess | double-strand break repair via break-induced replication | 2.36e-04 | 12 | 217 | 3 | GO:0000727 | |
| GeneOntologyBiologicalProcess | cell surface receptor signaling pathway via JAK-STAT | 2.58e-04 | 198 | 217 | 9 | GO:0007259 | |
| GeneOntologyBiologicalProcess | cell cycle process | MYH9 ZBTB17 ATRX INCENP CENPF SPTBN1 CUL9 MCM5 MCM6 MCM7 EZH2 BIRC6 CENPK POC1B GOLGA2 KPNB1 CUL2 POLE E4F1 MEI1 FANCM SKP2 EGF CEP72 SBDS CCDC102B RPA2 ANKFN1 CHMP1A NIN | 2.63e-04 | 1441 | 217 | 30 | GO:0022402 |
| GeneOntologyBiologicalProcess | B cell activation | HDAC9 EZH2 TBC1D10C MALT1 IFNA4 IFNA5 IFNA7 IFNA8 IFNA10 IFNA17 IFNA21 TXLNA | 2.79e-04 | 341 | 217 | 12 | GO:0042113 |
| GeneOntologyBiologicalProcess | response to organic cyclic compound | GABRB3 UBA5 NR2C1 ACACA SLC39A9 EZH2 FCSK PIK3CG NR1H4 CACNA1S NR2E3 NTRK2 SKP2 CRH IFNA4 IFNA5 IFNA7 IFNA8 IFNA10 IFNA17 IFNA21 EPG5 AKAP9 P2RX7 | 2.94e-04 | 1048 | 217 | 24 | GO:0014070 |
| GeneOntologyBiologicalProcess | DNA geometric change | 2.95e-04 | 86 | 217 | 6 | GO:0032392 | |
| GeneOntologyBiologicalProcess | constitutive heterochromatin formation | 3.04e-04 | 13 | 217 | 3 | GO:0140719 | |
| GeneOntologyBiologicalProcess | presynaptic membrane organization | 3.04e-04 | 13 | 217 | 3 | GO:0097090 | |
| GeneOntologyBiologicalProcess | territorial aggressive behavior | 3.28e-04 | 3 | 217 | 2 | GO:0002124 | |
| GeneOntologyBiologicalProcess | natural killer cell activation | 3.44e-04 | 124 | 217 | 7 | GO:0030101 | |
| GeneOntologyBiologicalProcess | B cell proliferation | 3.44e-04 | 124 | 217 | 7 | GO:0042100 | |
| GeneOntologyBiologicalProcess | regulation of defense response to virus | 3.78e-04 | 90 | 217 | 6 | GO:0050688 | |
| GeneOntologyBiologicalProcess | regulation of protein phosphorylation | INCENP EZH2 NEDD9 MALT1 PTPRO PIK3CG ULK4 TSACC NTRK2 RICTOR CRH IFNA4 IFNA5 PTPRT IFNA7 IFNA8 IFNA10 IFNA17 IFNA21 SPTBN4 EGF AKAP9 P2RX7 DOCK7 LRP4 | 3.81e-04 | 1133 | 217 | 25 | GO:0001932 |
| GeneOntologyBiologicalProcess | DNA-templated DNA replication maintenance of fidelity | 4.20e-04 | 60 | 217 | 5 | GO:0045005 | |
| GeneOntologyBiologicalProcess | regulation of protein modification process | INCENP EZH2 NEDD9 MALT1 PTPRO PIK3CG ULK4 ULK1 FBXO33 TSACC GOLGA2 NTRK2 RICTOR FANCM SKP2 CRH IFNA4 IFNA5 PTPRT IFNA7 IFNA8 IFNA10 IFNA17 IFNA21 SPTBN4 EGF AKAP9 P2RX7 DOCK7 LRP4 | 4.51e-04 | 1488 | 217 | 30 | GO:0031399 |
| GeneOntologyBiologicalProcess | regulation of phosphate metabolic process | MYH9 INCENP MCM7 EZH2 RYK NEDD9 MALT1 PTPRO PIK3CG ULK4 TSACC NR1H4 NTRK2 RICTOR CRH IFNA4 IFNA5 PTPRT IFNA7 IFNA8 IFNA10 IFNA17 IFNA21 SPTBN4 EGF AKAP9 P2RX7 DOCK7 LRP4 | 4.65e-04 | 1421 | 217 | 29 | GO:0019220 |
| GeneOntologyBiologicalProcess | regulation of phosphorus metabolic process | MYH9 INCENP MCM7 EZH2 RYK NEDD9 MALT1 PTPRO PIK3CG ULK4 TSACC NR1H4 NTRK2 RICTOR CRH IFNA4 IFNA5 PTPRT IFNA7 IFNA8 IFNA10 IFNA17 IFNA21 SPTBN4 EGF AKAP9 P2RX7 DOCK7 LRP4 | 4.75e-04 | 1423 | 217 | 29 | GO:0051174 |
| GeneOntologyBiologicalProcess | regulation of DNA-templated DNA replication initiation | 4.76e-04 | 15 | 217 | 3 | GO:0030174 | |
| GeneOntologyBiologicalProcess | DNA conformation change | 4.77e-04 | 94 | 217 | 6 | GO:0071103 | |
| GeneOntologyBiologicalProcess | organelle localization | MYH9 INCENP CENPF TRIP11 PIK3CG SYNE2 GOLGA2 KPNB1 SYNE1 MEI1 AKAP9 P2RX7 CLMN AP3B2 SLIT1 DOCK7 ANKFN1 CHMP1A | 4.81e-04 | 703 | 217 | 18 | GO:0051640 |
| GeneOntologyBiologicalProcess | centrosome localization | 4.83e-04 | 35 | 217 | 4 | GO:0051642 | |
| GeneOntologyBiologicalProcess | DNA replication | 4.91e-04 | 312 | 217 | 11 | GO:0006260 | |
| GeneOntologyBiologicalProcess | microtubule organizing center localization | 5.39e-04 | 36 | 217 | 4 | GO:0061842 | |
| GeneOntologyBiologicalProcess | membrane assembly | 5.67e-04 | 64 | 217 | 5 | GO:0071709 | |
| GeneOntologyBiologicalProcess | meiotic spindle organization | 5.99e-04 | 37 | 217 | 4 | GO:0000212 | |
| GeneOntologyBiologicalProcess | modulation of excitatory postsynaptic potential | 6.09e-04 | 65 | 217 | 5 | GO:0098815 | |
| GeneOntologyBiologicalProcess | DNA-templated DNA replication | 6.10e-04 | 178 | 217 | 8 | GO:0006261 | |
| GeneOntologyBiologicalProcess | spindle organization | 6.33e-04 | 224 | 217 | 9 | GO:0007051 | |
| GeneOntologyBiologicalProcess | male courtship behavior | 6.52e-04 | 4 | 217 | 2 | GO:0008049 | |
| GeneOntologyBiologicalProcess | cerebellum development | 6.84e-04 | 139 | 217 | 7 | GO:0021549 | |
| GeneOntologyBiologicalProcess | establishment of endothelial intestinal barrier | 7.00e-04 | 17 | 217 | 3 | GO:0090557 | |
| GeneOntologyBiologicalProcess | inner dynein arm assembly | 7.00e-04 | 17 | 217 | 3 | GO:0036159 | |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | CLSTN3 MYH9 SPTBN1 SPTBN2 TBC1D16 TBC1D10C NLGN4X CLU SRGAP3 SYNE2 ULK4 AFDN ULK1 BAIAP2L2 SYNE1 NTRK2 RICTOR FAF1 SPTBN4 AKAP9 P2RX7 TJP1 SLIT1 LRP4 CHMP1A | 7.68e-04 | 1189 | 217 | 25 | GO:0044087 |
| GeneOntologyBiologicalProcess | cell morphogenesis | CLSTN3 MYH9 TRIO RYK STRIP2 CLU PTPRO POC1B AFDN ULK1 FMNL1 GOLGA2 STRCP1 SYNE1 NTRK2 FAT3 FMNL3 SPTBN4 CDH22 P2RX7 SLIT1 DOCK7 LRP4 ZMYM3 NIN | 8.15e-04 | 1194 | 217 | 25 | GO:0000902 |
| GeneOntologyBiologicalProcess | double-strand break repair via homologous recombination | 8.71e-04 | 188 | 217 | 8 | GO:0000724 | |
| GeneOntologyBiologicalProcess | chemical synaptic transmission, postsynaptic | 9.51e-04 | 147 | 217 | 7 | GO:0099565 | |
| GeneOntologyBiologicalProcess | chromosome organization | ATRX MCM8 INCENP CENPF MCM5 MCM6 MCM7 EZH2 CENPK GOLGA2 KPNB1 HAT1 RECQL MEI1 FANCM RPA2 CHMP1A | 9.88e-04 | 686 | 217 | 17 | GO:0051276 |
| GeneOntologyBiologicalProcess | membrane biogenesis | 1.03e-03 | 73 | 217 | 5 | GO:0044091 | |
| GeneOntologyBiologicalProcess | axoneme assembly | 1.04e-03 | 109 | 217 | 6 | GO:0035082 | |
| GeneOntologyBiologicalProcess | recombinational repair | 1.07e-03 | 194 | 217 | 8 | GO:0000725 | |
| GeneOntologyBiologicalProcess | mini excitatory postsynaptic potential | 1.08e-03 | 5 | 217 | 2 | GO:0098816 | |
| GeneOntologyBiologicalProcess | regulation of mini excitatory postsynaptic potential | 1.08e-03 | 5 | 217 | 2 | GO:0061884 | |
| GeneOntologyBiologicalProcess | cerebrospinal fluid circulation | 1.15e-03 | 20 | 217 | 3 | GO:0090660 | |
| GeneOntologyBiologicalProcess | metencephalon development | 1.20e-03 | 153 | 217 | 7 | GO:0022037 | |
| GeneOntologyCellularComponent | MCM complex | 3.52e-06 | 11 | 217 | 4 | GO:0042555 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | CLSTN3 RYK NLGN4X PTPRO AFDN NLGN4Y GRIN2A PTPRT AKAP9 SORCS3 | 5.86e-06 | 157 | 217 | 10 | GO:0098839 |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | GABRB3 CLSTN3 RYK NLGN4X PTPRO AFDN NLGN4Y GRIN2A PTPRT AKAP9 SORCS3 | 8.58e-06 | 201 | 217 | 11 | GO:0099634 |
| GeneOntologyCellularComponent | postsynaptic specialization | GABRB3 CLSTN3 SPTBN1 DAPK1 RYK NLGN4X PTPRO AFDN NLGN4Y NTRK2 SH3GL1 GRIN2A PTPRT AKAP9 LRP4 SORCS3 | 7.73e-05 | 503 | 217 | 16 | GO:0099572 |
| GeneOntologyCellularComponent | postsynaptic density | CLSTN3 SPTBN1 DAPK1 RYK NLGN4X PTPRO AFDN NLGN4Y NTRK2 SH3GL1 GRIN2A PTPRT AKAP9 LRP4 SORCS3 | 7.93e-05 | 451 | 217 | 15 | GO:0014069 |
| GeneOntologyCellularComponent | spectrin | 8.85e-05 | 9 | 217 | 3 | GO:0008091 | |
| GeneOntologyCellularComponent | postsynaptic membrane | GABRB3 CLSTN3 RYK NLGN4X PTPRO AFDN NLGN4Y SYNE1 NTRK2 NBEA GRIN2A PTPRT AKAP9 SORCS3 | 9.17e-05 | 405 | 217 | 14 | GO:0045211 |
| GeneOntologyCellularComponent | axonemal dynein complex | 1.20e-04 | 25 | 217 | 4 | GO:0005858 | |
| GeneOntologyCellularComponent | inner dynein arm | 1.25e-04 | 10 | 217 | 3 | GO:0036156 | |
| GeneOntologyCellularComponent | synaptic membrane | GABRB3 CLSTN3 ADAM11 RYK NLGN4X PTPRO AFDN NLGN4Y SYNE1 NTRK2 NBEA GRIN2A PTPRT AKAP9 CNTNAP4 LRP4 SORCS3 | 1.33e-04 | 583 | 217 | 17 | GO:0097060 |
| GeneOntologyCellularComponent | asymmetric synapse | CLSTN3 SPTBN1 DAPK1 RYK NLGN4X PTPRO AFDN NLGN4Y NTRK2 SH3GL1 GRIN2A PTPRT AKAP9 LRP4 SORCS3 | 1.47e-04 | 477 | 217 | 15 | GO:0032279 |
| GeneOntologyCellularComponent | nuclear membrane protein complex | 1.71e-04 | 11 | 217 | 3 | GO:0106083 | |
| GeneOntologyCellularComponent | CMG complex | 1.71e-04 | 11 | 217 | 3 | GO:0071162 | |
| GeneOntologyCellularComponent | nuclear membrane microtubule tethering complex | 1.71e-04 | 11 | 217 | 3 | GO:0106094 | |
| GeneOntologyCellularComponent | microtubule organizing center attachment site | 1.71e-04 | 11 | 217 | 3 | GO:0034992 | |
| GeneOntologyCellularComponent | meiotic nuclear membrane microtubule tethering complex | 1.71e-04 | 11 | 217 | 3 | GO:0034993 | |
| GeneOntologyCellularComponent | DNA replication preinitiation complex | 2.92e-04 | 13 | 217 | 3 | GO:0031261 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | CLSTN3 SPTBN1 DAPK1 RYK NLGN4X PTPRO AFDN NLGN4Y NTRK2 SH3GL1 GRIN2A PTPRT AKAP9 LRP4 SORCS3 | 3.93e-04 | 523 | 217 | 15 | GO:0098984 |
| GeneOntologyCellularComponent | postsynapse | GABRB3 CLSTN3 TRIO SPTBN1 SPTBN2 DAPK1 RYK NLGN4X PTPRO SRGAP3 AFDN CACNA1S NLGN4Y SYNE1 NTRK2 SH3GL1 NBEA GRIN2A PTPRT AKAP9 P2RX7 LRP4 SORCS3 | 3.96e-04 | 1018 | 217 | 23 | GO:0098794 |
| GeneOntologyCellularComponent | symmetric, GABA-ergic, inhibitory synapse | 6.35e-04 | 4 | 217 | 2 | GO:0098983 | |
| GeneOntologyCellularComponent | excitatory synapse | 8.83e-04 | 107 | 217 | 6 | GO:0060076 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | 8.87e-04 | 238 | 217 | 9 | GO:0097729 | |
| GeneOntologyCellularComponent | dynein complex | 2.38e-03 | 54 | 217 | 4 | GO:0030286 | |
| GeneOntologyCellularComponent | chromosome, telomeric region | 2.47e-03 | 176 | 217 | 7 | GO:0000781 | |
| Domain | Interferon | 3.88e-10 | 17 | 212 | 7 | PF00143 | |
| Domain | INTERFERON_A_B_D | 3.88e-10 | 17 | 212 | 7 | PS00252 | |
| Domain | Interferon_alpha/beta/delta | 3.88e-10 | 17 | 212 | 7 | IPR000471 | |
| Domain | IFabd | 3.88e-10 | 17 | 212 | 7 | SM00076 | |
| Domain | Spectrin | 1.71e-07 | 23 | 212 | 6 | PF00435 | |
| Domain | ACTININ_2 | 1.71e-07 | 23 | 212 | 6 | PS00020 | |
| Domain | ACTININ_1 | 1.71e-07 | 23 | 212 | 6 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 1.71e-07 | 23 | 212 | 6 | IPR001589 | |
| Domain | Spectrin_repeat | 7.61e-07 | 29 | 212 | 6 | IPR002017 | |
| Domain | MCM_OB | 1.09e-06 | 8 | 212 | 4 | PF17207 | |
| Domain | MCM_OB | 1.09e-06 | 8 | 212 | 4 | IPR033762 | |
| Domain | MCM_2 | 1.09e-06 | 8 | 212 | 4 | PS50051 | |
| Domain | MCM_1 | 1.09e-06 | 8 | 212 | 4 | PS00847 | |
| Domain | SPEC | 1.41e-06 | 32 | 212 | 6 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 1.41e-06 | 32 | 212 | 6 | IPR018159 | |
| Domain | - | 1.45e-06 | 50 | 212 | 7 | 1.20.1250.10 | |
| Domain | 4_helix_cytokine_core | 1.67e-06 | 51 | 212 | 7 | IPR012351 | |
| Domain | 4_helix_cytokine-like_core | 1.91e-06 | 74 | 212 | 8 | IPR009079 | |
| Domain | MCM | 1.94e-06 | 9 | 212 | 4 | SM00350 | |
| Domain | MCM_dom | 1.94e-06 | 9 | 212 | 4 | IPR001208 | |
| Domain | MCM | 1.94e-06 | 9 | 212 | 4 | IPR031327 | |
| Domain | MCM | 1.94e-06 | 9 | 212 | 4 | PF00493 | |
| Domain | Spectrin_bsu | 5.72e-06 | 4 | 212 | 3 | IPR016343 | |
| Domain | ARM-type_fold | CUL9 PIK3CG ULK4 FMNL1 KPNB1 RAP1GDS1 IPO8 RICTOR NBEA HEATR1 MEI1 FMNL3 CEBPZ MROH2B AP3B2 | 8.07e-06 | 339 | 212 | 15 | IPR016024 |
| Domain | Dynein_heavy_chain_D4_dom | 1.48e-05 | 14 | 212 | 4 | IPR024317 | |
| Domain | Dynein_HC_stalk | 1.48e-05 | 14 | 212 | 4 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.48e-05 | 14 | 212 | 4 | IPR013602 | |
| Domain | DHC_N2 | 1.48e-05 | 14 | 212 | 4 | PF08393 | |
| Domain | MT | 1.48e-05 | 14 | 212 | 4 | PF12777 | |
| Domain | AAA_8 | 1.48e-05 | 14 | 212 | 4 | PF12780 | |
| Domain | DHC_fam | 2.00e-05 | 15 | 212 | 4 | IPR026983 | |
| Domain | Dynein_heavy | 2.00e-05 | 15 | 212 | 4 | PF03028 | |
| Domain | Dynein_heavy_dom | 2.00e-05 | 15 | 212 | 4 | IPR004273 | |
| Domain | MCM_N | 2.81e-05 | 6 | 212 | 3 | PF14551 | |
| Domain | MCM_CS | 2.81e-05 | 6 | 212 | 3 | IPR018525 | |
| Domain | MCM_N | 2.81e-05 | 6 | 212 | 3 | IPR027925 | |
| Domain | AAA | 4.00e-05 | 144 | 212 | 9 | SM00382 | |
| Domain | AAA+_ATPase | 4.00e-05 | 144 | 212 | 9 | IPR003593 | |
| Domain | DHC_N1 | 7.74e-05 | 8 | 212 | 3 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 7.74e-05 | 8 | 212 | 3 | IPR013594 | |
| Domain | CH | 9.42e-05 | 65 | 212 | 6 | SM00033 | |
| Domain | PH_dom-spectrin-type | 1.15e-04 | 9 | 212 | 3 | IPR001605 | |
| Domain | NLGN4 | 1.28e-04 | 2 | 212 | 2 | IPR030025 | |
| Domain | CH | 1.43e-04 | 70 | 212 | 6 | PF00307 | |
| Domain | - | 1.54e-04 | 71 | 212 | 6 | 1.10.418.10 | |
| Domain | CH | 1.80e-04 | 73 | 212 | 6 | PS50021 | |
| Domain | CH-domain | 2.09e-04 | 75 | 212 | 6 | IPR001715 | |
| Domain | ARM-like | CUL9 ULK4 KPNB1 RAP1GDS1 IPO8 RICTOR NBEA HEATR1 MEI1 MROH2B AP3B2 | 2.72e-04 | 270 | 212 | 11 | IPR011989 |
| Domain | ABC_A | 2.94e-04 | 12 | 212 | 3 | IPR026082 | |
| Domain | 5-nucleotidase | 3.82e-04 | 3 | 212 | 2 | PF06189 | |
| Domain | 5-nucleotidase | 3.82e-04 | 3 | 212 | 2 | IPR010394 | |
| Domain | ATPase_dyneun-rel_AAA | 4.79e-04 | 14 | 212 | 3 | IPR011704 | |
| Domain | AAA_5 | 4.79e-04 | 14 | 212 | 3 | PF07728 | |
| Domain | - | 7.48e-04 | 95 | 212 | 6 | 2.60.120.200 | |
| Domain | KASH | 7.58e-04 | 4 | 212 | 2 | IPR012315 | |
| Domain | KASH | 7.58e-04 | 4 | 212 | 2 | PS51049 | |
| Domain | KASH | 7.58e-04 | 4 | 212 | 2 | SM01249 | |
| Domain | MAPKKKK | 7.58e-04 | 4 | 212 | 2 | IPR021160 | |
| Domain | KASH | 7.58e-04 | 4 | 212 | 2 | PF10541 | |
| Domain | Rubredoxin-type_fold | 7.58e-04 | 4 | 212 | 2 | IPR004039 | |
| Domain | - | 7.58e-04 | 4 | 212 | 2 | 2.20.28.10 | |
| Domain | SH3 | 8.32e-04 | 216 | 212 | 9 | SM00326 | |
| Domain | SH3 | 8.32e-04 | 216 | 212 | 9 | PS50002 | |
| Domain | LAM_G_DOMAIN | 8.80e-04 | 38 | 212 | 4 | PS50025 | |
| Domain | SH3_domain | 9.47e-04 | 220 | 212 | 9 | IPR001452 | |
| Domain | - | 1.01e-03 | 222 | 212 | 9 | 1.25.10.10 | |
| Domain | Laminin_G_2 | 1.07e-03 | 40 | 212 | 4 | PF02210 | |
| Domain | Nlgn | 1.25e-03 | 5 | 212 | 2 | IPR000460 | |
| Domain | P-loop_NTPase | MYH9 ATRX MCM8 MYO1E DAPK1 MCM5 MCM6 MCM7 ABCA10 ABCA9 ABCA8 DNAH9 DNAH10 DNAH2 RECQL FANCM DNAH7 ARHGAP5 TJP1 MYH15 | 1.64e-03 | 848 | 212 | 20 | IPR027417 |
| Domain | Tesmin/TSO1-like_CXC | 1.87e-03 | 6 | 212 | 2 | IPR033467 | |
| Domain | CXC | 1.87e-03 | 6 | 212 | 2 | SM01114 | |
| Domain | CA | 2.01e-03 | 115 | 212 | 6 | SM00112 | |
| Domain | Cadherin | 2.29e-03 | 118 | 212 | 6 | IPR002126 | |
| Domain | NA-bd_OB-fold | 2.55e-03 | 83 | 212 | 5 | IPR012340 | |
| Domain | Cullin_CS | 2.59e-03 | 7 | 212 | 2 | IPR016157 | |
| Domain | SH3_1 | 2.73e-03 | 164 | 212 | 7 | PF00018 | |
| Pathway | KEGG_REGULATION_OF_AUTOPHAGY | 2.01e-10 | 35 | 167 | 9 | M6382 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_TAT_TO_TLR2_4_NFKB_SIGNALING_PATHWAY | 5.08e-10 | 17 | 167 | 7 | M47564 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CGAS_STING_SIGNALING_PATHWAY | 8.23e-10 | 18 | 167 | 7 | M47539 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF7_SIGNALING_PATHWAY | 1.29e-09 | 19 | 167 | 7 | M47450 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR7_9_IRF7_SIGNALING_PATHWAY | 1.97e-09 | 20 | 167 | 7 | M47617 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_II_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY | 2.92e-09 | 21 | 167 | 7 | M47909 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR7_8_9_IRF5_SIGNALING_PATHWAY | 4.24e-09 | 22 | 167 | 7 | M47897 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RIG_I_NFKB_SIGNALING_PATHWAY | 4.24e-09 | 22 | 167 | 7 | M47616 | |
| Pathway | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | 4.58e-09 | 34 | 167 | 8 | MM15631 | |
| Pathway | REACTOME_REGULATION_OF_IFNA_IFNB_SIGNALING | 6.03e-09 | 23 | 167 | 7 | MM15634 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_I_IFN_SIGNALING_PATHWAY | 6.03e-09 | 23 | 167 | 7 | M47452 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MDA5_IRF7_3_SIGNALING_PATHWAY | 8.43e-09 | 24 | 167 | 7 | M47782 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RIG_I_IRF7_3_SIGNALING_PATHWAY | 8.43e-09 | 24 | 167 | 7 | M47576 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_I_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY | 8.43e-09 | 24 | 167 | 7 | M47908 | |
| Pathway | REACTOME_REGULATION_OF_IFNA_IFNB_SIGNALING | 1.57e-08 | 26 | 167 | 7 | M982 | |
| Pathway | BIOCARTA_CYTOKINE_PATHWAY | 2.77e-08 | 28 | 167 | 7 | MM1378 | |
| Pathway | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION | 4.67e-08 | 30 | 167 | 7 | M936 | |
| Pathway | WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY | 5.98e-08 | 31 | 167 | 7 | M39897 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IFN_RIPK1_3_SIGNALING_PATHWAY | 5.98e-08 | 31 | 167 | 7 | M47964 | |
| Pathway | BIOCARTA_IFNA_PATHWAY | 6.03e-08 | 19 | 167 | 6 | MM1571 | |
| Pathway | REACTOME_EVASION_BY_RSV_OF_HOST_INTERFERON_RESPONSES | 1.47e-07 | 35 | 167 | 7 | M48246 | |
| Pathway | WP_INTERFERONMEDIATED_SIGNALING | 2.20e-07 | 37 | 167 | 7 | M39785 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX | 1.77e-06 | 32 | 167 | 6 | MM15368 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX | 2.15e-06 | 33 | 167 | 6 | M9694 | |
| Pathway | BIOCARTA_INFLAM_PATHWAY | 2.15e-06 | 33 | 167 | 6 | MM1379 | |
| Pathway | KEGG_AUTOIMMUNE_THYROID_DISEASE | 2.47e-06 | 52 | 167 | 7 | M13103 | |
| Pathway | KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY | 3.63e-06 | 55 | 167 | 7 | M11844 | |
| Pathway | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | 3.80e-06 | 78 | 167 | 8 | M973 | |
| Pathway | WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE | 5.96e-06 | 39 | 167 | 6 | MM15914 | |
| Pathway | BIOCARTA_IL1R_PATHWAY | 8.06e-06 | 41 | 167 | 6 | MM1493 | |
| Pathway | REACTOME_UNWINDING_OF_DNA | 8.73e-06 | 12 | 167 | 4 | M3656 | |
| Pathway | PID_CD8_TCR_DOWNSTREAM_PATHWAY | 1.13e-05 | 65 | 167 | 7 | M272 | |
| Pathway | REACTOME_DNA_REPLICATION | 1.75e-05 | 125 | 167 | 9 | MM15380 | |
| Pathway | REACTOME_DNA_REPLICATION_PRE_INITIATION | 1.94e-05 | 97 | 167 | 8 | MM15369 | |
| Pathway | KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY | 2.03e-05 | 71 | 167 | 7 | M15913 | |
| Pathway | REACTOME_MITOTIC_G1_PHASE_AND_G1_S_TRANSITION | 2.39e-05 | 130 | 167 | 9 | MM15146 | |
| Pathway | WP_CYTOSOLIC_DNASENSING_PATHWAY | 2.44e-05 | 73 | 167 | 7 | M39837 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ORIGIN_UNWINDING_AND_ELONGATION | 2.46e-05 | 30 | 167 | 5 | M47859 | |
| Pathway | KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY | 2.80e-05 | 102 | 167 | 8 | M3261 | |
| Pathway | WP_TOLLLIKE_RECEPTOR_SIGNALING | 3.00e-05 | 103 | 167 | 8 | M39434 | |
| Pathway | REACTOME_G1_S_TRANSITION | 3.22e-05 | 104 | 167 | 8 | MM15376 | |
| Pathway | REACTOME_DNA_STRAND_ELONGATION | 3.42e-05 | 32 | 167 | 5 | M19312 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | 3.85e-05 | 138 | 167 | 9 | MM15635 | |
| Pathway | REACTOME_RHOJ_GTPASE_CYCLE | 4.53e-05 | 55 | 167 | 6 | M41815 | |
| Pathway | REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA | 5.21e-05 | 82 | 167 | 7 | M1002 | |
| Pathway | KEGG_DNA_REPLICATION | 6.15e-05 | 36 | 167 | 5 | M16853 | |
| Pathway | REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS | 6.15e-05 | 36 | 167 | 5 | MM14687 | |
| Pathway | REACTOME_MITOTIC_G1_PHASE_AND_G1_S_TRANSITION | 7.00e-05 | 149 | 167 | 9 | M848 | |
| Pathway | REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS | 7.05e-05 | 37 | 167 | 5 | M11153 | |
| Pathway | WP_IL2_SIGNALING_PATHWAY | 7.61e-05 | 87 | 167 | 7 | MM15915 | |
| Pathway | KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION | 8.19e-05 | 88 | 167 | 7 | M16004 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BREAK_INDUCED_REPLICATION | 8.75e-05 | 8 | 167 | 3 | M47840 | |
| Pathway | REACTOME_SYNTHESIS_OF_DNA | 9.48e-05 | 121 | 167 | 8 | M5224 | |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | 9.50e-05 | 155 | 167 | 9 | M41808 | |
| Pathway | KEGG_MEDICUS_REFERENCE_DNA_REPLICATION_TERMINATION | 9.72e-05 | 21 | 167 | 4 | M47861 | |
| Pathway | WP_DNA_REPLICATION | 1.31e-04 | 42 | 167 | 5 | M39335 | |
| Pathway | REACTOME_S_PHASE | 1.39e-04 | 163 | 167 | 9 | M3158 | |
| Pathway | REACTOME_RSV_HOST_INTERACTIONS | 1.62e-04 | 98 | 167 | 7 | M48247 | |
| Pathway | REACTOME_ORC1_REMOVAL_FROM_CHROMATIN | 1.63e-04 | 69 | 167 | 6 | MM15366 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 1.84e-04 | 10 | 167 | 3 | MM15112 | |
| Pathway | REACTOME_ORC1_REMOVAL_FROM_CHROMATIN | 1.91e-04 | 71 | 167 | 6 | M4138 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | 1.92e-04 | 170 | 167 | 9 | M941 | |
| Pathway | REACTOME_CELL_CYCLE | ATRX MCM8 INCENP CENPF LIN54 PSMB3 MCM5 MCM6 MCM7 CENPK SYNE2 GOLGA2 KPNB1 SYNE1 POLE COP1 SKP2 AKAP9 CEP72 RPA2 | 2.09e-04 | 694 | 167 | 20 | M543 |
| Pathway | KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY | 2.25e-04 | 137 | 167 | 8 | M5669 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PURINE_SALVAGE_PATHWAY_HYPOXANTHINE_GUANINE_TO_IMP_GMP | 2.51e-04 | 11 | 167 | 3 | M47820 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PURINE_SALVAGE_PATHWAY_ADENINE_TO_AMP | 2.51e-04 | 11 | 167 | 3 | M47819 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PRE_IC_FORMATION | 2.70e-04 | 27 | 167 | 4 | M47858 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 2.70e-04 | 27 | 167 | 4 | M47755 | |
| Pathway | REACTOME_CELL_CYCLE | ATRX MCM8 INCENP CENPF LIN54 PSMB3 MCM5 MCM6 MCM7 CENPK GOLGA2 KPNB1 POLE COP1 SKP2 AKAP9 CEP72 RPA2 | 2.89e-04 | 603 | 167 | 18 | MM14635 |
| Pathway | REACTOME_S_PHASE | 3.46e-04 | 146 | 167 | 8 | MM15378 | |
| Pathway | REACTOME_DNA_REPLICATION | 3.88e-04 | 187 | 167 | 9 | M1017 | |
| Pathway | REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX | 3.94e-04 | 81 | 167 | 6 | MM15360 | |
| Pathway | KEGG_JAK_STAT_SIGNALING_PATHWAY | 5.16e-04 | 155 | 167 | 8 | M17411 | |
| Pathway | REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY | 5.60e-04 | 120 | 167 | 7 | M48233 | |
| Pathway | REACTOME_DNA_REPLICATION_PRE_INITIATION | 6.11e-04 | 159 | 167 | 8 | M27665 | |
| Pathway | WP_RETINOBLASTOMA_GENE_IN_CANCER | 6.92e-04 | 90 | 167 | 6 | M39678 | |
| Pathway | REACTOME_SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE | 6.92e-04 | 90 | 167 | 6 | MM15371 | |
| Pathway | REACTOME_SARS_COV_2_HOST_INTERACTIONS | 7.29e-04 | 204 | 167 | 9 | M45011 | |
| Pathway | REACTOME_SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES | 7.49e-04 | 126 | 167 | 7 | M45009 | |
| Pathway | WP_G1_TO_S_CELL_CYCLE_CONTROL | 7.65e-04 | 61 | 167 | 5 | MM15912 | |
| Pathway | REACTOME_SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE | 7.77e-04 | 92 | 167 | 6 | M27666 | |
| Pathway | WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS | 7.84e-04 | 127 | 167 | 7 | M42533 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TRAIP_DEPENDENT_REPLISOME_DISASSEMBLY | 8.16e-04 | 16 | 167 | 3 | M47862 | |
| Pathway | WP_G1_TO_S_CELL_CYCLE_CONTROL | 9.53e-04 | 64 | 167 | 5 | M39627 | |
| Pathway | REACTOME_CELL_CYCLE_MITOTIC | MCM8 INCENP CENPF LIN54 PSMB3 MCM5 MCM6 MCM7 CENPK GOLGA2 KPNB1 POLE SKP2 AKAP9 CEP72 RPA2 | 1.03e-03 | 561 | 167 | 16 | M5336 |
| Pathway | BIOCARTA_MCM_PATHWAY | 1.17e-03 | 18 | 167 | 3 | M6682 | |
| Pathway | WP_MEASLES_VIRUS_INFECTION | 1.17e-03 | 136 | 167 | 7 | M42547 | |
| Pathway | REACTOME_SIGNALING_BY_FLT3_FUSION_PROTEINS | 1.38e-03 | 19 | 167 | 3 | M41732 | |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | 1.46e-03 | 271 | 167 | 10 | MM15388 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 1.64e-03 | 43 | 167 | 4 | M47669 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | ACACA PIK3CG ULK1 IFNA4 IFNA5 IFNA7 IFNA8 IFNA10 IFNA17 IFNA21 EGF | 1.75e-03 | 326 | 167 | 11 | MM15917 |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 1.94e-03 | 45 | 167 | 4 | M47670 | |
| Pathway | WP_HEPATITIS_B_INFECTION | 2.14e-03 | 151 | 167 | 7 | M39801 | |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | 2.47e-03 | 291 | 167 | 10 | M16647 | |
| Pathway | KEGG_MEDICUS_REFERENCE_DNA_REPLICATION_LICENSING | 2.75e-03 | 24 | 167 | 3 | M47857 | |
| Pubmed | 3.03e-13 | 12 | 222 | 7 | 16565497 | ||
| Pubmed | Evolution of the interferon alpha gene family in eutherian mammals. | 3.03e-13 | 12 | 222 | 7 | 17512142 | |
| Pubmed | Repression of the murine interferon alpha 11 gene: identification of negatively acting sequences. | 3.03e-13 | 12 | 222 | 7 | 1886773 | |
| Pubmed | Multiple pathways of interferon-induced gene expression in murine macrophages. | 3.03e-13 | 12 | 222 | 7 | 7684767 | |
| Pubmed | Negative regulation of the alpha interferon-induced antiviral response by the Ras/Raf/MEK pathway. | 3.03e-13 | 12 | 222 | 7 | 16611902 | |
| Pubmed | Interferon-alpha subtype 11 activates NK cells and enables control of retroviral infection. | 3.03e-13 | 12 | 222 | 7 | 22912583 | |
| Pubmed | Structure and expression of a new murine interferon-alpha gene: MuIFN-alpha I9. | 3.03e-13 | 12 | 222 | 7 | 3758677 | |
| Pubmed | 3.03e-13 | 12 | 222 | 7 | 8245849 | ||
| Pubmed | 3.03e-13 | 12 | 222 | 7 | 11846978 | ||
| Pubmed | Identification of distal silencing elements in the murine interferon-A11 gene promoter. | 3.03e-13 | 12 | 222 | 7 | 8760352 | |
| Pubmed | Role of interferons in the regulation of cell proliferation, differentiation, and development. | 3.03e-13 | 12 | 222 | 7 | 7530016 | |
| Pubmed | 3.03e-13 | 12 | 222 | 7 | 9794206 | ||
| Pubmed | 3.03e-13 | 12 | 222 | 7 | 17451966 | ||
| Pubmed | Characterization of interferon-alpha 13, a novel constitutive murine interferon-alpha subtype. | 6.52e-13 | 13 | 222 | 7 | 12930842 | |
| Pubmed | Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. | 6.52e-13 | 13 | 222 | 7 | 2014240 | |
| Pubmed | 6.52e-13 | 13 | 222 | 7 | 18005734 | ||
| Pubmed | 6.52e-13 | 13 | 222 | 7 | 12050368 | ||
| Pubmed | Isolation and bacterial expression of a murine alpha leukocyte interferon gene. | 6.52e-13 | 13 | 222 | 7 | 6094686 | |
| Pubmed | 6.52e-13 | 13 | 222 | 7 | 1655578 | ||
| Pubmed | 6.52e-13 | 13 | 222 | 7 | 2471809 | ||
| Pubmed | 6.52e-13 | 13 | 222 | 7 | 8438572 | ||
| Pubmed | 6.52e-13 | 13 | 222 | 7 | 9343822 | ||
| Pubmed | Evidence for a different susceptibility of primate lentiviruses to type I interferons. | 6.52e-13 | 13 | 222 | 7 | 23255800 | |
| Pubmed | 6.52e-13 | 13 | 222 | 7 | 7523540 | ||
| Pubmed | 6.52e-13 | 13 | 222 | 7 | 19706714 | ||
| Pubmed | Organization, structure and expression of murine interferon alpha genes. | 6.52e-13 | 13 | 222 | 7 | 2987810 | |
| Pubmed | 6.52e-13 | 13 | 222 | 7 | 19130550 | ||
| Pubmed | 6.52e-13 | 13 | 222 | 7 | 22739040 | ||
| Pubmed | 6.52e-13 | 13 | 222 | 7 | 9181467 | ||
| Pubmed | Sequencing and bacterial expression of a novel murine alpha interferon gene. | 6.52e-13 | 13 | 222 | 7 | 18726328 | |
| Pubmed | 6.52e-13 | 13 | 222 | 7 | 18572754 | ||
| Pubmed | Alpha interferon suppresses the cyclin D3 and cdc25A genes, leading to a reversible G0-like arrest. | 1.30e-12 | 14 | 222 | 7 | 8668211 | |
| Pubmed | Interferon induction by HIV glycoprotein 120: role of the V3 loop. | 1.30e-12 | 14 | 222 | 7 | 7526537 | |
| Pubmed | 1.30e-12 | 14 | 222 | 7 | 19559726 | ||
| Pubmed | 1.30e-12 | 14 | 222 | 7 | 15240719 | ||
| Pubmed | 1.30e-12 | 14 | 222 | 7 | 16418394 | ||
| Pubmed | 1.30e-12 | 14 | 222 | 7 | 18272764 | ||
| Pubmed | 1.30e-12 | 14 | 222 | 7 | 11884139 | ||
| Pubmed | 1.30e-12 | 14 | 222 | 7 | 19004943 | ||
| Pubmed | 1.30e-12 | 14 | 222 | 7 | 2552026 | ||
| Pubmed | Modulation of interferon-mediated inhibition of human immunodeficiency virus type 1 by Tat. | 1.30e-12 | 14 | 222 | 7 | 7532202 | |
| Pubmed | 1.30e-12 | 14 | 222 | 7 | 18200012 | ||
| Pubmed | Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. | 1.30e-12 | 14 | 222 | 7 | 18200009 | |
| Pubmed | A structural basis for interferon-alpha-receptor interactions. | 1.30e-12 | 14 | 222 | 7 | 17517919 | |
| Pubmed | 1.30e-12 | 14 | 222 | 7 | 14983024 | ||
| Pubmed | 1.30e-12 | 14 | 222 | 7 | 25972534 | ||
| Pubmed | 1.30e-12 | 14 | 222 | 7 | 7583919 | ||
| Pubmed | 1.30e-12 | 14 | 222 | 7 | 2987811 | ||
| Pubmed | 1.30e-12 | 14 | 222 | 7 | 21172865 | ||
| Pubmed | Characterization of the murine alpha interferon gene family. | 1.30e-12 | 14 | 222 | 7 | 15254193 | |
| Pubmed | 1.30e-12 | 14 | 222 | 7 | 16278001 | ||
| Pubmed | Recombinant glycoprotein 120 of human immunodeficiency virus is a potent interferon inducer. | 1.30e-12 | 14 | 222 | 7 | 1381203 | |
| Pubmed | 1.30e-12 | 14 | 222 | 7 | 8345204 | ||
| Pubmed | 2.42e-12 | 15 | 222 | 7 | 8786318 | ||
| Pubmed | 2.42e-12 | 15 | 222 | 7 | 15684736 | ||
| Pubmed | 2.42e-12 | 15 | 222 | 7 | 9520456 | ||
| Pubmed | Are CD4 and Fas peptide identities of gp120 relevant to the molecular basis of AIDS pathogenesis? | 2.42e-12 | 15 | 222 | 7 | 17180012 | |
| Pubmed | Role of the Akt pathway in mRNA translation of interferon-stimulated genes. | 2.42e-12 | 15 | 222 | 7 | 18339807 | |
| Pubmed | Interferon induction by HIV-1-infected cells: a possible role of sulfatides or related glycolipids. | 2.42e-12 | 15 | 222 | 7 | 8661419 | |
| Pubmed | Role of retroviral restriction factors in the interferon-α-mediated suppression of HIV-1 in vivo. | 4.28e-12 | 16 | 222 | 7 | 22315404 | |
| Pubmed | Coordinate induction of interferon alpha and gamma by recombinant HIV-1 glycoprotein 120. | 4.28e-12 | 16 | 222 | 7 | 7904170 | |
| Pubmed | Sialoadhesin expressed on IFN-induced monocytes binds HIV-1 and enhances infectivity. | 4.28e-12 | 16 | 222 | 7 | 18414664 | |
| Pubmed | MYH9 TRIO CENPF SPTBN1 SPTBN2 DAPK1 GIT2 TRIP11 LRIG2 HOOK1 CLU SRGAP3 SYNE2 AFDN GOLGA2 GOLGB1 KPNB1 SYNE1 NTRK2 NBEA GRIN2A SPTBN4 TXLNA AKAP9 P2RX7 TJP1 DOCK7 FRMPD3 LRRC15 | 5.11e-12 | 963 | 222 | 29 | 28671696 | |
| Pubmed | 7.23e-12 | 17 | 222 | 7 | 22814248 | ||
| Pubmed | Characterization of the type I interferon locus and identification of novel genes. | 7.23e-12 | 17 | 222 | 7 | 15233997 | |
| Pubmed | 1.18e-11 | 18 | 222 | 7 | 1905933 | ||
| Pubmed | 1.85e-11 | 19 | 222 | 7 | 7511078 | ||
| Pubmed | 1.85e-11 | 19 | 222 | 7 | 7815507 | ||
| Pubmed | 1.85e-11 | 19 | 222 | 7 | 17360657 | ||
| Pubmed | Translational regulation by HIV leader RNA, TAT, and interferon-inducible enzymes. | 1.85e-11 | 19 | 222 | 7 | 1708818 | |
| Pubmed | 1.85e-11 | 19 | 222 | 7 | 1385305 | ||
| Pubmed | TYK2 and JAK2 are substrates of protein-tyrosine phosphatase 1B. | 2.84e-11 | 20 | 222 | 7 | 11694501 | |
| Pubmed | 2.84e-11 | 20 | 222 | 7 | 8764000 | ||
| Pubmed | 2.84e-11 | 11 | 222 | 6 | 18835032 | ||
| Pubmed | High-affinity binding of 125I-labelled mouse interferon to a specific cell surface receptor. | 2.84e-11 | 11 | 222 | 6 | 6444699 | |
| Pubmed | Structural and functional neuropathology in transgenic mice with CNS expression of IFN-alpha. | 2.84e-11 | 11 | 222 | 6 | 10448195 | |
| Pubmed | IFN-alpha can both protect against and promote the development of type 1 diabetes. | 2.84e-11 | 11 | 222 | 6 | 19120292 | |
| Pubmed | Effect of interferon-alpha on immediate early gene expression of murine cytomegalovirus. | 2.84e-11 | 11 | 222 | 6 | 8389790 | |
| Pubmed | The mouse IFN-alpha (Ifa) locus: correlation of physical and linkage maps by in situ hybridization. | 2.84e-11 | 11 | 222 | 6 | 3456887 | |
| Pubmed | Mechanism of SUMOylation-Mediated Regulation of Type I IFN Expression. | 2.84e-11 | 11 | 222 | 6 | 36681180 | |
| Pubmed | Type I interferon dependence of plasmacytoid dendritic cell activation and migration. | 2.84e-11 | 11 | 222 | 6 | 15795237 | |
| Pubmed | 2.84e-11 | 11 | 222 | 6 | 9794439 | ||
| Pubmed | 2.84e-11 | 11 | 222 | 6 | 25310498 | ||
| Pubmed | Maps from two interspecific backcross DNA panels available as a community genetic mapping resource. | 3.48e-11 | 72 | 222 | 10 | 8075499 | |
| Pubmed | 4.23e-11 | 21 | 222 | 7 | 9108403 | ||
| Pubmed | Regulation of effector and memory T-cell functions by type I interferon. | 5.66e-11 | 12 | 222 | 6 | 21320124 | |
| Pubmed | MAVS Deficiency Is Associated With a Reduced T Cell Response Upon Secondary RSV Infection in Mice. | 5.66e-11 | 12 | 222 | 6 | 33123150 | |
| Pubmed | A novel anti-viral role for STAT3 in IFN-α signalling responses. | 5.66e-11 | 12 | 222 | 6 | 27988795 | |
| Pubmed | 5.66e-11 | 12 | 222 | 6 | 9425112 | ||
| Pubmed | 5.66e-11 | 12 | 222 | 6 | 8656058 | ||
| Pubmed | The physical separation of Lps and Ifa loci in BXH recombinant inbred mice. | 5.66e-11 | 12 | 222 | 6 | 2572648 | |
| Pubmed | Developmental control of IFN-alpha expression in murine embryos. | 5.66e-11 | 12 | 222 | 6 | 7925651 | |
| Pubmed | The role of type 1 interferons in coagulation induced by gram-negative bacteria. | 5.66e-11 | 12 | 222 | 6 | 32016282 | |
| Pubmed | 5.66e-11 | 12 | 222 | 6 | 6188104 | ||
| Pubmed | Ligation of CD180 inhibits IFN-α signaling in a Lyn-PI3K-BTK-dependent manner in B cells. | 5.66e-11 | 12 | 222 | 6 | 26277892 | |
| Pubmed | 5.66e-11 | 12 | 222 | 6 | 6689487 | ||
| Pubmed | Interferon-alpha initiates type 1 diabetes in nonobese diabetic mice. | 5.66e-11 | 12 | 222 | 6 | 18716002 | |
| Pubmed | 5.66e-11 | 12 | 222 | 6 | 30967261 | ||
| Pubmed | 5.66e-11 | 12 | 222 | 6 | 23747509 | ||
| Pubmed | 5.66e-11 | 12 | 222 | 6 | 17434974 | ||
| Interaction | PFN1 interactions | MYH9 TRIO SPTBN1 GIT2 NHLRC2 EZH2 BIRC6 TRIP11 FASN SYNE2 AFDN FMNL1 GOLGA2 GOLGB1 NBEA ARHGAP5 RNF123 AKAP9 TJP1 DOCK7 RPA2 | 1.73e-07 | 509 | 218 | 21 | int:PFN1 |
| Interaction | IFNA5 interactions | 3.21e-06 | 22 | 218 | 5 | int:IFNA5 | |
| Interaction | IFNA13 interactions | 4.14e-06 | 11 | 218 | 4 | int:IFNA13 | |
| Interaction | TNIK interactions | TRIO CENPF SPTBN1 SPTBN2 HOOK1 CLU SRGAP3 SYNE2 SYNE1 NTRK2 NBEA GRIN2A AKAP9 TJP1 DOCK7 RPA2 | 4.29e-06 | 381 | 218 | 16 | int:TNIK |
| Interaction | ACTN1 interactions | MYH9 DAPK1 MCM5 GIT2 EZH2 CLU GOLGB1 RECQL RICTOR GRIN2A TFCP2 FAF1 TJP1 MYH15 RPA2 | 4.94e-06 | 341 | 218 | 15 | int:ACTN1 |
| Interaction | IFIT1 interactions | 5.79e-06 | 64 | 218 | 7 | int:IFIT1 | |
| Interaction | SVIL interactions | MYH9 ATRX CENPF SPTBN1 DAPK1 MRTFB HOOK1 RICTOR P2RX7 RPA2 STOM NIN | 9.35e-06 | 233 | 218 | 12 | int:SVIL |
| Interaction | KDM1A interactions | NR2C1 MYH9 ACACA CENPF LIN54 CCDC90B MCM7 CCDC172 EZH2 BIRC6 ZBTB24 MALT1 FASN MRTFB CLU SRGAP3 KRT222 TSACC GOLGA2 GOLGB1 CCDC93 AKAP9 DOCK7 RPA2 ZMYM3 NIN | 1.13e-05 | 941 | 218 | 26 | int:KDM1A |
| Interaction | CARM1 interactions | SLC39A9 PSMB3 EZH2 MALT1 FASN NR1H4 CUL2 RICTOR SKP2 FAF1 RNF123 MAP4K5 SMS RPA2 | 1.30e-05 | 325 | 218 | 14 | int:CARM1 |
| Interaction | PCNT interactions | ACACA SPTBN1 SPTBN2 TRIP11 FASN POC1B IPO8 SYNE1 AKAP9 CEP72 RPA2 NIN | 1.31e-05 | 241 | 218 | 12 | int:PCNT |
| Interaction | ZBBX interactions | 1.91e-05 | 31 | 218 | 5 | int:ZBBX | |
| Interaction | SIRT7 interactions | MYH9 ACACA INCENP CENPF SPTBN1 SPTBN2 CUL9 MCM5 MCM6 MCM7 BIRC6 FASN SYNE2 AFDN KPNB1 POLE RECQL HEATR1 CEBPZ TJP1 DOCK7 ZMYM3 | 2.02e-05 | 744 | 218 | 22 | int:SIRT7 |
| Interaction | H4C2 interactions | 2.50e-05 | 54 | 218 | 6 | int:H4C2 | |
| Interaction | MAB21L2 interactions | 2.62e-05 | 143 | 218 | 9 | int:MAB21L2 | |
| Interaction | H4C13 interactions | 3.79e-05 | 58 | 218 | 6 | int:H4C13 | |
| Interaction | IFNA16 interactions | 4.23e-05 | 7 | 218 | 3 | int:IFNA16 | |
| Interaction | KCTD13 interactions | GABRB3 MYH9 MYO1E TRIO SPTBN1 SPTBN2 PSMB3 DAPK1 TRIP11 FASN FAU PNPLA6 CLU SRGAP3 AFDN AKR1B1 MTUS2 KPNB1 GPD2 RAP1GDS1 MAP4K3 SYNE1 SH3GL1 NBEA GRIN2A FAF1 SPTBN4 ARHGAP5 TJP1 CLMN AP3B2 DOCK7 | 4.36e-05 | 1394 | 218 | 32 | int:KCTD13 |
| Interaction | FBXL18 interactions | 4.60e-05 | 60 | 218 | 6 | int:FBXL18 | |
| Interaction | PTP4A3 interactions | 4.69e-05 | 154 | 218 | 9 | int:PTP4A3 | |
| Interaction | MCM7 interactions | ACACA ATRX MCM8 MCM5 MCM6 MCM7 EZH2 MYLK4 GOLGA2 SH3GL1 COP1 RECQL MIPOL1 CCDC102B RPA2 | 4.80e-05 | 414 | 218 | 15 | int:MCM7 |
| Interaction | MCM8 interactions | 5.06e-05 | 61 | 218 | 6 | int:MCM8 | |
| Interaction | PRC1 interactions | BDP1 MYH9 ATRX MYO1E INCENP CENPF SPTBN1 SPTBN2 MCM5 MCM6 MCM7 FASN GOLGB1 CCDC93 KPNB1 CUL2 SYNE1 RECQL HEATR1 SPTBN4 AKAP9 CEBPZ TJP1 CNTNAP4 RPA2 | 5.58e-05 | 973 | 218 | 25 | int:PRC1 |
| Interaction | IFNA4 interactions | 7.72e-05 | 41 | 218 | 5 | int:IFNA4 | |
| Interaction | PARP1 interactions | HDAC9 NR2C1 MYO1E INCENP DAPK1 MCM5 MCM6 MCM7 EZH2 ZBTB24 RYK FASN ULK1 FMNL1 GPD2 CUL2 RAP1GDS1 POLE HAT1 RECQL RICTOR E4F1 HEATR1 TFCP2 FAF1 ARHGAP5 CEBPZ DOCK7 RPA2 ZMYM3 | 8.78e-05 | 1316 | 218 | 30 | int:PARP1 |
| Interaction | MBD3 interactions | NR2C1 ACACA ATRX MCM7 EZH2 BIRC6 FASN MTUS2 GOLGA2 CUL2 HAT1 MIPOL1 | 9.40e-05 | 295 | 218 | 12 | int:MBD3 |
| Interaction | IFNA7 interactions | 1.00e-04 | 9 | 218 | 3 | int:IFNA7 | |
| Interaction | UBR3 interactions | 1.01e-04 | 99 | 218 | 7 | int:UBR3 | |
| Interaction | H4C6 interactions | 1.02e-04 | 69 | 218 | 6 | int:H4C6 | |
| Interaction | DSCAM interactions | 1.05e-04 | 171 | 218 | 9 | int:DSCAM | |
| Interaction | MYO1C interactions | MYH9 MYO1E SPTBN1 SPTBN2 DAPK1 MCM5 EZH2 GOLGA2 COP1 RICTOR TFCP2 TJP1 DOCK7 RPA2 | 1.14e-04 | 397 | 218 | 14 | int:MYO1C |
| Interaction | CYFIP1 interactions | MYH9 SPTBN1 SPTBN2 CUL9 EZH2 RYK GOLGA2 NTRK2 RICTOR GRIN2A P2RX7 RPA2 | 1.21e-04 | 303 | 218 | 12 | int:CYFIP1 |
| Interaction | STK25 interactions | 1.38e-04 | 104 | 218 | 7 | int:STK25 | |
| Interaction | MCM3 interactions | ATRX SPTBN1 MCM5 MCM6 MCM7 NHLRC2 EZH2 CUL2 HAT1 FAF1 SMS RPA2 NIN | 1.38e-04 | 355 | 218 | 13 | int:MCM3 |
| Interaction | SNX27 interactions | FNBP1 CDS1 MCM5 GIT2 NLGN4X CLU AFDN GPD2 IPO8 RICTOR CEBPZ TJP1 AKAP10 RPA2 ACAP2 STOM | 1.42e-04 | 509 | 218 | 16 | int:SNX27 |
| Interaction | CDT1 interactions | 1.50e-04 | 74 | 218 | 6 | int:CDT1 | |
| Interaction | FXR1 interactions | MYH9 CENPF GIT2 EZH2 CLU AFDN MTUS2 GOLGA2 GOLGB1 CCDC93 KPNB1 PCED1A RECQL RICTOR AKAP9 CEP72 SLIT1 DOCK7 RPA2 | 1.55e-04 | 679 | 218 | 19 | int:FXR1 |
| Interaction | H4C9 interactions | 1.74e-04 | 108 | 218 | 7 | int:H4C9 | |
| Interaction | HYOU1 interactions | DAPK1 MCM7 EZH2 FREM2 HOOK1 CLU PTPRO GOLGA2 RAP1GDS1 RICTOR CCDC39 RPA2 | 1.84e-04 | 317 | 218 | 12 | int:HYOU1 |
| Interaction | CAPZA1 interactions | MYH9 SPTBN1 PSMB3 DAPK1 EZH2 HOOK1 CUL2 TFCP2 FRK DOCK7 SMS RPA2 NIN | 1.87e-04 | 366 | 218 | 13 | int:CAPZA1 |
| Interaction | H4C3 interactions | 2.02e-04 | 50 | 218 | 5 | int:H4C3 | |
| Interaction | DSCR9 interactions | 2.03e-04 | 147 | 218 | 8 | int:DSCR9 | |
| Interaction | ACTR1A interactions | FNBP1 MYH9 SPTBN1 SPTBN2 MCM6 MCM7 HOOK1 DNAH10 RICTOR RPA2 NIN | 2.06e-04 | 274 | 218 | 11 | int:ACTR1A |
| Interaction | SH3GLB2 interactions | 2.06e-04 | 111 | 218 | 7 | int:SH3GLB2 | |
| Interaction | FLOT1 interactions | MYH9 INCENP TRIO SPTBN1 SPTBN2 CCDC90B EZH2 RICTOR TFCP2 CAPN10 TJP1 MYH15 CCDC102B RPA2 NIN | 2.18e-04 | 475 | 218 | 15 | int:FLOT1 |
| Interaction | CDC42 interactions | FNBP1 ACACA MYO1E TRIO SPTBN1 SPTBN2 MCM6 MCM7 GIT2 EZH2 TRIP11 RPUSD3 SYNE2 AFDN AKR1B1 FMNL1 GOLGB1 RAP1GDS1 SYNE1 RICTOR HEATR1 TXNDC12 FMNL3 ARHGAP5 CEBPZ TJP1 DOCK7 RPA2 STOM | 2.27e-04 | 1323 | 218 | 29 | int:CDC42 |
| Interaction | EPOP interactions | 2.43e-04 | 52 | 218 | 5 | int:EPOP | |
| Interaction | CEP192 interactions | 2.52e-04 | 192 | 218 | 9 | int:CEP192 | |
| Interaction | DISC1 interactions | TRIO SPTBN1 TRIP11 CLU SRGAP3 GOLGA2 SYNE1 SKP2 SPTBN4 RNF123 AKAP9 LRP4 CCDC102B FLACC1 | 2.54e-04 | 429 | 218 | 14 | int:DISC1 |
| Interaction | RANBP3L interactions | 2.56e-04 | 12 | 218 | 3 | int:RANBP3L | |
| Interaction | FAM186B interactions | 2.56e-04 | 12 | 218 | 3 | int:FAM186B | |
| Interaction | IFNA2 interactions | 2.56e-04 | 12 | 218 | 3 | int:IFNA2 | |
| Interaction | SMC4 interactions | FNBP1 MYH9 ACACA MCM6 EZH2 HOOK1 COP1 RICTOR FRK RNF123 RPA2 | 2.56e-04 | 281 | 218 | 11 | int:SMC4 |
| Cytoband | 9p22 | 2.51e-11 | 25 | 222 | 7 | 9p22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9p21 | 2.62e-06 | 124 | 222 | 7 | chr9p21 | |
| Cytoband | 12q24.3 | 3.45e-04 | 6 | 222 | 2 | 12q24.3 | |
| GeneFamily | Interferons | 5.51e-09 | 32 | 146 | 7 | 598 | |
| GeneFamily | MCM family | 4.98e-07 | 9 | 146 | 4 | 1085 | |
| GeneFamily | Dyneins, axonemal | 8.95e-06 | 17 | 146 | 4 | 536 | |
| GeneFamily | EF-hand domain containing|Spectrins | 1.76e-05 | 7 | 146 | 3 | 1113 | |
| GeneFamily | ATP binding cassette subfamily A | 1.76e-04 | 14 | 146 | 3 | 805 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 3.84e-04 | 4 | 146 | 2 | 1252 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinase kinases | 6.37e-04 | 5 | 146 | 2 | 655 | |
| GeneFamily | CD molecules|5'-nucleotidases | 1.32e-03 | 7 | 146 | 2 | 1042 | |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 1.62e-03 | 29 | 146 | 3 | 396 | |
| GeneFamily | Cullins | 1.76e-03 | 8 | 146 | 2 | 1032 | |
| GeneFamily | Bone morphogenetic proteins|Astacins | 3.40e-03 | 11 | 146 | 2 | 455 | |
| GeneFamily | X-linked mental retardation|RNA helicases | 3.40e-03 | 11 | 146 | 2 | 1168 | |
| Coexpression | ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_NAIVE_NOT_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP | 3.47e-08 | 39 | 222 | 7 | M41095 | |
| Coexpression | SHIN_B_CELL_LYMPHOMA_CLUSTER_5 | 1.39e-07 | 29 | 222 | 6 | MM586 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | MYH9 MYO1E INCENP TRIO CENPF SPTBN1 NEDD9 RICTOR ARHGAP5 CEP72 NIN | 1.14e-06 | 199 | 222 | 11 | M5893 |
| Coexpression | HALLMARK_G2M_CHECKPOINT | 1.20e-06 | 200 | 222 | 11 | M5901 | |
| Coexpression | GROSS_HYPOXIA_VIA_HIF1A_DN | 1.84e-06 | 131 | 222 | 9 | MM1127 | |
| Coexpression | IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP | FREM2 RECQL IFNA4 IFNA5 IFNA7 IFNA8 IFNA10 IFNA17 IFNA21 AKAP10 ACAP2 | 1.93e-06 | 210 | 222 | 11 | MM751 |
| Coexpression | LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_DT_ANTIBODY_CORRELATION_PROFILE_3DY_UP | 2.89e-06 | 27 | 222 | 5 | M40935 | |
| Coexpression | LEE_AGING_NEOCORTEX_DN | 5.35e-06 | 80 | 222 | 7 | MM646 | |
| Coexpression | LEE_CALORIE_RESTRICTION_NEOCORTEX_DN | 8.02e-06 | 85 | 222 | 7 | MM684 | |
| Coexpression | LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_POLYSACCHARIDE_ANTIBODY_CORRELATION_PROFILE_3DY_DN | 8.42e-06 | 16 | 222 | 4 | M40964 | |
| Coexpression | FISCHER_DREAM_TARGETS | ACACA MCM8 INCENP CENPF LIN54 MCM5 MCM6 MCM7 EZH2 BIRC6 CENPK KPNB1 GPD2 POLE HAT1 HEATR1 FANCM SKP2 FAF1 TXNDC12 CEP72 PBX3 RPA2 | 9.09e-06 | 969 | 222 | 23 | M149 |
| Coexpression | LEE_CALORIE_RESTRICTION_NEOCORTEX_UP | 9.36e-06 | 87 | 222 | 7 | MM652 | |
| Coexpression | MARSON_BOUND_BY_E2F4_UNSTIMULATED | ATRX MCM8 INCENP SNAPC5 MCM5 MCM6 MCM7 EZH2 CENPK KPNB1 GPD2 RECQL FANCM SKP2 TXNDC12 TXLNA CEP72 SBDS RPA2 | 1.19e-05 | 714 | 222 | 19 | M1744 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 2.43e-05 | 180 | 222 | 9 | M8239 | |
| Coexpression | LINDGREN_BLADDER_CANCER_CLUSTER_3_UP | MCM8 CENPF DAPK1 MCM5 MCM6 EZH2 NEDD9 AFDN NCEH1 NTRK2 FAF1 TTC39A | 2.56e-05 | 328 | 222 | 12 | M854 |
| Coexpression | VERNELL_RETINOBLASTOMA_PATHWAY_UP | 2.65e-05 | 69 | 222 | 6 | M15969 | |
| Coexpression | GSE6259_33D1_POS_DC_VS_CD4_TCELL_UP | 2.89e-05 | 184 | 222 | 9 | M6756 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | MCM8 INCENP CENPF MCM5 MCM6 MCM7 EZH2 CENPK CLU POLE HAT1 SKP2 RPA2 | 4.26e-05 | 402 | 222 | 13 | MM454 |
| Coexpression | GSE22196_HEALTHY_VS_OBESE_MOUSE_SKIN_GAMMADELTA_TCELL_UP | 5.33e-05 | 199 | 222 | 9 | M7655 | |
| Coexpression | HEVNER_CORTEX_PROLIFERATING_CELLS | 5.51e-05 | 25 | 222 | 4 | MM433 | |
| Coexpression | GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_UP | 5.54e-05 | 200 | 222 | 9 | M7168 | |
| Coexpression | FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN | 5.87e-05 | 49 | 222 | 5 | M11250 | |
| Coexpression | WORSCHECH_TUMOR_REJECTION_UP | 6.15e-05 | 80 | 222 | 6 | MM1229 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | BDP1 FNBP1 CLSTN3 MYH9 ATRX GIT2 BIRC6 NEDD9 TBC1D10C MALT1 FAU GVINP1 SRGAP3 FMNL1 KPNB1 TYW3 RAP1GDS1 SYNE1 PLEKHF1 RICTOR EPG5 FMNL3 AKAP9 AKAP10 RPA2 ACAP2 STOM NIN | 6.82e-05 | 1492 | 222 | 28 | M40023 |
| Coexpression | ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR | 8.09e-05 | 84 | 222 | 6 | M2606 | |
| Coexpression | GSE21360_SECONDARY_VS_TERTIARY_MEMORY_CD8_TCELL_DN | 9.33e-05 | 167 | 222 | 8 | M7621 | |
| Coexpression | MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS | 1.19e-04 | 90 | 222 | 6 | M39250 | |
| Coexpression | RB_P107_DN.V1_UP | 1.24e-04 | 130 | 222 | 7 | M2802 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | MCM8 INCENP CENPF LIN54 MCM5 MCM6 MCM7 EZH2 CENPK POC1B POLE HAT1 SKP2 FMNL3 RPA2 | 1.33e-04 | 578 | 222 | 15 | M2368 |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 1.40e-04 | 177 | 222 | 8 | M39245 | |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_UP | 1.75e-04 | 183 | 222 | 8 | M2993 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | MCM8 INCENP CENPF LIN54 MCM5 MCM6 MCM7 EZH2 CENPK POC1B POLE HAT1 SKP2 FMNL3 RPA2 | 1.89e-04 | 597 | 222 | 15 | MM1309 |
| Coexpression | ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_RESPONDERS_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP | 1.90e-04 | 34 | 222 | 4 | M41094 | |
| Coexpression | GSE13173_UNTREATED_VS_IL12_TREATED_ACT_CD8_TCELL_DN | 2.06e-04 | 141 | 222 | 7 | M465 | |
| Coexpression | GSE19198_1H_VS_6H_IL21_TREATED_TCELL_UP | 2.11e-04 | 188 | 222 | 8 | M7224 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | MCM8 CENPF MCM5 CENPK HOOK1 MED12L POLE HAT1 RECQL HEATR1 FAF1 CEP72 SMS RPA2 | 1.39e-05 | 361 | 208 | 14 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k2_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000 | CDS1 MCM8 INCENP CENPF SPTBN2 MCM5 CCDC172 PHKA2 PTPN3 HOOK1 MED12L CUL2 POLE HAT1 RECQL HEATR1 FANCM FAF1 AP3B2 SMS RPA2 | 6.13e-05 | 822 | 208 | 21 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000 |
| CoexpressionAtlas | alpha beta T cells, T.ISP.Th, 4- 8+ TCR-/lo 24hi, Thymus, avg-3 | MCM8 INCENP CENPF MCM5 MCM6 MCM7 EZH2 CENPK STRIP2 POLE HAT1 FANCM SKP2 RPA2 | 6.73e-05 | 417 | 208 | 14 | GSM399403_500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | B3GALT1 ATRX MCM8 CENPF LIN54 SPTBN2 MCM7 EZH2 CENPK TBC1D16 HOOK1 SRGAP3 RPUSD3 SYNE2 TTLL1 GPD2 IPO8 FAT3 HAT1 FANCM FAF1 AKAP9 AP3B2 SLIT1 DOCK7 SMS PBX3 ANKFN1 STOM | 7.36e-05 | 1370 | 208 | 29 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | BDP1 MCM8 INCENP APCDD1 CENPF BIRC6 HOOK1 KPNB1 POLE NTRK2 THUMPD3 FANCM ZHX2 CEBPZ TJP1 LRP4 | 7.52e-05 | 532 | 208 | 16 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_1000 | CDS1 MCM8 INCENP CENPF SPTBN2 MCM7 CCDC172 PTPN3 HOOK1 KRT222 TSACC CUL2 POLE HAT1 RECQL HEATR1 FAF1 CEBPZ AP3B2 RPA2 | 1.14e-04 | 795 | 208 | 20 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_500 | CDS1 MCM8 CENPF SPTBN2 CCDC172 PTPN3 HOOK1 KRT222 CUL2 POLE HAT1 HEATR1 RPA2 | 1.22e-04 | 387 | 208 | 13 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_500 |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | CROCC2 SYNE2 ULK4 VWA3B DNAH9 DNAH10 SYNE1 DNAH2 DNAH7 CCDC39 PTPRT AKAP9 FLACC1 CFAP157 | 1.44e-12 | 197 | 222 | 14 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | CROCC2 ULK4 DNAH9 FBXW10 DNAH10 SYNE1 DNAH2 NBEA DNAH7 CCDC39 CFAP157 | 4.11e-09 | 194 | 222 | 11 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.06e-08 | 164 | 222 | 10 | 5621c2e3fae84d5a2e4f1595e454bcb3a2b3f93c | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | CROCC2 DNAH9 DNAH10 DNAH2 NBEA DNAH7 PTPRT SLIT1 ANKFN1 CFAP157 | 1.41e-08 | 169 | 222 | 10 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | CROCC2 VWA3B DNAH9 DNAH10 DNAH2 DNAH7 CCDC39 PTPRT ANKFN1 CFAP157 | 2.85e-08 | 182 | 222 | 10 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | CDS1 CROCC2 VWA3B DNAH9 DNAH10 DNAH2 DNAH7 PTPRT ANKFN1 CFAP157 | 4.50e-08 | 191 | 222 | 10 | e81cd65dbf0ef1c2ab7088f73ce605d456dd3a7a |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | CROCC2 ULK4 VWA3B DNAH9 DNAH10 DNAH2 DNAH7 CCDC39 PTPRT ANKFN1 | 4.96e-08 | 193 | 222 | 10 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | MRTFB SRGAP3 VWA3B DNAH9 DNAH10 DNAH2 DNAH7 CCDC39 CLMN CFAP157 | 4.96e-08 | 193 | 222 | 10 | ea345d34440b25f65358a53dc72831998d1c3620 |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-DN_to_DP_transition,_dividing_(more_DN)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.96e-08 | 193 | 222 | 10 | 40eedc1490c113403bc7c12a6bdf976f4f8bca84 | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | CROCC2 ULK4 VWA3B DNAH9 DNAH10 SYNE1 DNAH2 DNAH7 PTPRT ANKFN1 | 4.96e-08 | 193 | 222 | 10 | ad58f5080e0ba65c845056ea6b79037b636e9c64 |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | SPTBN1 SYNE2 VWA3B DNAH9 DNAH10 SYNE1 NBEA DNAH7 PTPRT ANKFN1 | 5.47e-08 | 195 | 222 | 10 | fce0c29574bb7aab181b9c00feb42681e285d1f2 |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | SPTBN1 SYNE2 VWA3B DNAH9 DNAH10 SYNE1 NBEA DNAH7 PTPRT ANKFN1 | 5.47e-08 | 195 | 222 | 10 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | VWA3B DNAH9 DNAH10 SYNE1 DNAH2 DNAH7 CCDC39 AKAP9 CLMN CFAP157 | 6.02e-08 | 197 | 222 | 10 | 91637bdeab85024b5a02d1066f76cb803a2d6420 |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | VWA3B DNAH9 DNAH10 SYNE1 DNAH2 DNAH7 CCDC39 AKAP9 CLMN CFAP157 | 6.02e-08 | 197 | 222 | 10 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | VWA3B DNAH9 DNAH10 SYNE1 DNAH2 DNAH7 CCDC39 AKAP9 CLMN CFAP157 | 6.02e-08 | 197 | 222 | 10 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | VWA3B DNAH9 DNAH10 SYNE1 DNAH2 DNAH7 CCDC39 AKAP9 CLMN CFAP157 | 6.02e-08 | 197 | 222 | 10 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | CROCC2 VWA3B DNAH9 DNAH10 DNAH2 DNAH7 CCDC39 PTPRT ANKFN1 CFAP157 | 6.93e-08 | 200 | 222 | 10 | 85c98da55f7cd4ffdf9d309b56c8cc5d43f3c04c |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | CROCC2 VWA3B DNAH9 DNAH10 DNAH2 DNAH7 CCDC39 PTPRT ANKFN1 CFAP157 | 6.93e-08 | 200 | 222 | 10 | 12bc7d95c4166d12487081a76d210b7abe5991b0 |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.40e-08 | 154 | 222 | 9 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.40e-08 | 154 | 222 | 9 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.86e-07 | 169 | 222 | 9 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.75e-07 | 177 | 222 | 9 | 8a74f5e72de605774111057bd87a7e7e4a6385cd | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.17e-07 | 180 | 222 | 9 | 92fb01b91261b3103454924cde56add337b41844 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.48e-07 | 182 | 222 | 9 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.81e-07 | 184 | 222 | 9 | 5daff849625f2f41d56615569c0ed59cd733b34c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.99e-07 | 185 | 222 | 9 | 3e39a3cb534dfe2301930f3e2f7e8cefb522c158 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 3.99e-07 | 185 | 222 | 9 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-Proliferating_T_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.99e-07 | 185 | 222 | 9 | 0e0f043ad6d2a62cd47ce39911ad81feab4a4d7e | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.99e-07 | 185 | 222 | 9 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | 15-Airway-Epithelial-Multiciliated_cell|Airway / Age, Tissue, Lineage and Cell class | 3.99e-07 | 185 | 222 | 9 | 0998b6bf44287eebbf39249fff23fc3689e44c4e | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.99e-07 | 185 | 222 | 9 | 89b85ce8026dc80c1bd9f76dfe16401c173b7946 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.99e-07 | 185 | 222 | 9 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.37e-07 | 187 | 222 | 9 | 9e10ed56090d82589bc457788282f664b70ace4b | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 4.57e-07 | 188 | 222 | 9 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 4.57e-07 | 188 | 222 | 9 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.57e-07 | 188 | 222 | 9 | 2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3 | |
| ToppCell | COVID-19-lung-Ciliated|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.78e-07 | 189 | 222 | 9 | a2da5debd10f27b1280b40141ef0bfef007cc72c | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 4.78e-07 | 189 | 222 | 9 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.78e-07 | 189 | 222 | 9 | 68a3cf7763d6f9b95d6d6524eff7a16042703f1d | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 4.78e-07 | 189 | 222 | 9 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 4.78e-07 | 189 | 222 | 9 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | PBMC-Severe-cDC_12|Severe / Compartment, Disease Groups and Clusters | 5.00e-07 | 190 | 222 | 9 | 84ee185939bdefb10705b621a70da27701eadcee | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.22e-07 | 191 | 222 | 9 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.22e-07 | 191 | 222 | 9 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.22e-07 | 191 | 222 | 9 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.22e-07 | 191 | 222 | 9 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.22e-07 | 191 | 222 | 9 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 5.45e-07 | 192 | 222 | 9 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.95e-07 | 194 | 222 | 9 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.21e-07 | 195 | 222 | 9 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.21e-07 | 195 | 222 | 9 | c1435e61e4f0cf457f26ae436936048932ceb0db | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.48e-07 | 196 | 222 | 9 | a156840330630e518bc85633dded6f2c3ead3b30 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.48e-07 | 196 | 222 | 9 | 009e83c7251cf300be78b263634d233a8d972a68 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.48e-07 | 196 | 222 | 9 | a37ba02446eef5d1fab703204583f6550a8ec3e1 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.48e-07 | 196 | 222 | 9 | 89ea4d2086e1c769c5a87f1471a6cd4acabcfe33 | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 6.48e-07 | 196 | 222 | 9 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.76e-07 | 197 | 222 | 9 | a0d463825b62de49466f9fa563405dda4387cfff | |
| ToppCell | COVID-CD4-exh_CD4|COVID / Condition, Cell_class and T cell subcluster | 6.76e-07 | 197 | 222 | 9 | 39ee4b93625c994813044d8dd8854fba2bd99940 | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.05e-07 | 198 | 222 | 9 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.36e-07 | 199 | 222 | 9 | 1df69c0cb5f759f6a2152521842506a75bb95cae | |
| ToppCell | medial-Epithelial-Ciliated|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.36e-07 | 199 | 222 | 9 | a2daa42b100c422dc8c04fb7d2ebf54293eef574 | |
| ToppCell | BAL-Mild-Epithelial|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.36e-07 | 199 | 222 | 9 | 74087b4b5e567310fc4ac58fb267ff651a180680 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.36e-07 | 199 | 222 | 9 | 1ee4010d8557564e25e8ee00b914c2dfd9037838 | |
| ToppCell | medial-Epithelial-Ciliated-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.36e-07 | 199 | 222 | 9 | 526002f16bbf61cf086278d45a401cc0b0b757a8 | |
| ToppCell | distal-Epithelial-Ciliated|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.36e-07 | 199 | 222 | 9 | 18ca031cfe702afb9bf94e03c0f3680c38e7599e | |
| ToppCell | medial-2-Epithelial-Ciliated|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.36e-07 | 199 | 222 | 9 | c02f04a5aa79ee0cf427f6e94b93ceab38ebbcd7 | |
| ToppCell | BAL-Mild-Epithelial|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.36e-07 | 199 | 222 | 9 | 00b5ce099c50a5e1786ce2b3a06ee0931a8205a4 | |
| ToppCell | distal-2-Epithelial-Ciliated|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.36e-07 | 199 | 222 | 9 | 97b66b82c76c7bc1fcd7da7b94dd2aa2d4d70a60 | |
| ToppCell | Mild_COVID-19-Epithelial|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 7.36e-07 | 199 | 222 | 9 | 72689bda7476930887ae007682fcab27f956f050 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.67e-07 | 200 | 222 | 9 | 0cf7208eab0dc58fbea35e256c5cb55cdd4a4928 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.67e-07 | 200 | 222 | 9 | 55c148238d5c80c1faa3428a917ae8075be2c145 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.67e-07 | 200 | 222 | 9 | a4ec0e80f5422b91b85264a9bb74568dd577e285 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.67e-07 | 200 | 222 | 9 | 926a7ea94b5908aebf103893ea83ce9d25285b65 | |
| ToppCell | mild-T/NK_proliferative|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.67e-07 | 200 | 222 | 9 | 25b4a1a33348e274bd4457efc0d6faa5421c3d31 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.67e-07 | 200 | 222 | 9 | 06ce6e03498ba38ef6a06eaf2731e3b2eeda59eb | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.67e-07 | 200 | 222 | 9 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.67e-07 | 200 | 222 | 9 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.67e-07 | 200 | 222 | 9 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.67e-07 | 200 | 222 | 9 | 31d75c26055177d656df1fbb10b764cebd61e122 | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.67e-07 | 200 | 222 | 9 | 4992dbf0514d674017315dbd20d91dfec0c608e9 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.67e-07 | 200 | 222 | 9 | e1dce91c6c531bb212002a14705e496d77ad3490 | |
| ToppCell | mild-T/NK_proliferative|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.67e-07 | 200 | 222 | 9 | 63cc57b9331459efbb73051d174d198a3568b938 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.93e-07 | 150 | 222 | 8 | 7bc61eb4b8c4a1909f4b7bcd1c6a88ef46102669 | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-Sox9_Epi-Sox9_Epi_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.20e-06 | 156 | 222 | 8 | b28bbdb515317368f1231b0b15d7442352f3b400 | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.45e-06 | 160 | 222 | 8 | 5cc1b75e3c20d83112b3aa2f3c749a6c73910a2d | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.00e-06 | 167 | 222 | 8 | 859dfe0764cb69de27e79e1c1aa65f9d538f79ea | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.72e-06 | 174 | 222 | 8 | c988471207ba06195bc3e41056435e8c31c20bbe | |
| ToppCell | Ciliated_cells-A-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 3.22e-06 | 178 | 222 | 8 | 255473ee6df8a13079fb3bb61038162a40cb4c2c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.22e-06 | 178 | 222 | 8 | de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-06 | 178 | 222 | 8 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.22e-06 | 178 | 222 | 8 | c77a1d1a9aef0ab51b4408b9e84f201219788ca2 | |
| ToppCell | Ciliated_cells-A-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.35e-06 | 179 | 222 | 8 | 0e6c22de2e3fb0ff23b3301863cf4011c5c59dff | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.64e-06 | 181 | 222 | 8 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.45e-06 | 186 | 222 | 8 | 85787ff207f109ec7e3c0f729ba9bda739c2fdc9 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-F_(Ciliated)|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.45e-06 | 186 | 222 | 8 | 708c5edefe36c91df27cf53c1b5101fb2030cc5a | |
| ToppCell | Ciliated_cells-B-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 4.45e-06 | 186 | 222 | 8 | f72267d533fd0c5280d9741ceee3dd116300a7e4 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.45e-06 | 186 | 222 | 8 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | 390C-Epithelial_cells-Epithelial-F_(Ciliated)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.45e-06 | 186 | 222 | 8 | 029390c4aaf64e6bcd86124cd4a6dd2e6f3a374b | |
| ToppCell | Ciliated_cells-B-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 4.63e-06 | 187 | 222 | 8 | bc1f33f332ac939c2425f510173430ca2ba0c3ee | |
| ToppCell | Ciliated_cells-B-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 4.63e-06 | 187 | 222 | 8 | 2b4262c2e7c7830a976be168cee6eeb738d4feda | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 9.98e-07 | 49 | 119 | 7 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Drug | Yfrkd | 1.63e-09 | 7 | 219 | 5 | CID000129984 | |
| Drug | 1hiv | 4.30e-09 | 8 | 219 | 5 | CID005479205 | |
| Drug | Chebi:36708 | 4.30e-09 | 8 | 219 | 5 | CID011966289 | |
| Drug | pipobroman | 1.91e-08 | 10 | 219 | 5 | CID000004842 | |
| Drug | flesinoxan | 3.47e-08 | 11 | 219 | 5 | CID000057347 | |
| Drug | 2',3'-dideoxycytidine (ddC | 4.87e-08 | 76 | 219 | 9 | CID000005718 | |
| Drug | FMAU | 5.58e-08 | 37 | 219 | 7 | CID000072327 | |
| Drug | R 842 | 9.51e-08 | 13 | 219 | 5 | CID000130714 | |
| Drug | AC1O52EF | 9.51e-08 | 13 | 219 | 5 | CID006450817 | |
| Drug | AC1L9FQV | 9.54e-08 | 82 | 219 | 9 | CID000444118 | |
| Drug | Lanicemine | 1.47e-07 | 14 | 219 | 5 | CID003038485 | |
| Drug | gunacin | 1.47e-07 | 14 | 219 | 5 | CID000198547 | |
| Drug | pppA2'-5'A2'-5'A | 2.18e-07 | 15 | 219 | 5 | CID000125229 | |
| Drug | DZNep | 3.62e-07 | 30 | 219 | 6 | CID000073087 | |
| Drug | YNK01 | 4.43e-07 | 17 | 219 | 5 | CID000084071 | |
| Drug | trifluorothymidine | 5.59e-07 | 51 | 219 | 7 | CID000006256 | |
| Drug | p203 | 6.09e-07 | 18 | 219 | 5 | CID000019228 | |
| Drug | podophyllin | 6.09e-07 | 18 | 219 | 5 | CID011979494 | |
| Drug | Nyco | 6.09e-07 | 18 | 219 | 5 | CID000071618 | |
| Drug | AC1L1GVK | 6.93e-07 | 76 | 219 | 8 | CID000003860 | |
| Drug | m IU | 1.08e-06 | 56 | 219 | 7 | CID006852123 | |
| Drug | Ciluprevir [USAN] | 1.08e-06 | 20 | 219 | 5 | CID006450803 | |
| Drug | val-mCyd | 1.08e-06 | 20 | 219 | 5 | CID006918726 | |
| Drug | L DO | 1.41e-06 | 21 | 219 | 5 | CID000097725 | |
| Drug | formosanin C | 1.81e-06 | 22 | 219 | 5 | CID000073597 | |
| Drug | Hiltonol | 2.30e-06 | 23 | 219 | 5 | CID000431963 | |
| Drug | AC1L1ZCT | 2.88e-06 | 24 | 219 | 5 | CID000038235 | |
| Drug | cycloferon | 2.88e-06 | 24 | 219 | 5 | CID000038072 | |
| Drug | Murabutida | 3.35e-06 | 43 | 219 | 6 | CID005362018 | |
| Drug | barium iodide | 3.49e-06 | 4 | 219 | 3 | CID000083684 | |
| Drug | hycanthone | 3.57e-06 | 25 | 219 | 5 | CID000003634 | |
| Drug | LB80380 | 3.57e-06 | 25 | 219 | 5 | CID006480442 | |
| Drug | 2-chloro-3'-deoxyadenosine | 3.85e-06 | 44 | 219 | 6 | CID003034808 | |
| Drug | ABMP | 4.39e-06 | 26 | 219 | 5 | CID000080567 | |
| Drug | Solvent Yellow-?14 | 5.02e-06 | 46 | 219 | 6 | CID005354458 | |
| Drug | inosiplex | 5.34e-06 | 27 | 219 | 5 | CID000037510 | |
| Drug | VX-497 | 5.34e-06 | 27 | 219 | 5 | CID000153241 | |
| Drug | AC1NRD2B | 6.45e-06 | 28 | 219 | 5 | CID005289317 | |
| Drug | D-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Thr-NH2 | 7.32e-06 | 49 | 219 | 6 | CID000365716 | |
| Drug | NSC141633 | 7.74e-06 | 29 | 219 | 5 | CID000003628 | |
| Drug | NM 108 | 7.74e-06 | 29 | 219 | 5 | CID000500901 | |
| Drug | B132 | 8.65e-06 | 5 | 219 | 3 | CID002734031 | |
| Drug | penciclovir | 9.21e-06 | 30 | 219 | 5 | CID000004725 | |
| Drug | poly rI:rC | 9.21e-06 | 30 | 219 | 5 | CID011979660 | |
| Drug | NSC105014 | 1.14e-05 | 110 | 219 | 8 | CID000001546 | |
| Drug | CHEMBL466993 | 1.28e-05 | 32 | 219 | 5 | CID005320808 | |
| Drug | HCV-371 | 1.72e-05 | 6 | 219 | 3 | CID003013096 | |
| Drug | carprofen | 1.74e-05 | 34 | 219 | 5 | CID000002581 | |
| Drug | oxymatrine | 1.74e-05 | 34 | 219 | 5 | CID000114850 | |
| Drug | tenofovir disoproxil fumarate | 1.74e-05 | 34 | 219 | 5 | CID005481350 | |
| Drug | tilorone | 2.02e-05 | 35 | 219 | 5 | CID000005475 | |
| Drug | lobucavir | 2.02e-05 | 35 | 219 | 5 | CID000060786 | |
| Drug | ethanol | GABRB3 SPTBN1 SPTBN2 BIRC6 NT5C1A PIK3CG GPD2 IPO8 POLE NTRK2 GRIN2A NT5C1B CRH IFNA4 IFNA5 IFNA7 IFNA10 IFNA17 SPTBN4 EGF RPA2 CHMP1A | 2.07e-05 | 837 | 219 | 22 | CID000000702 |
| Drug | Bromopride [4093-35-0]; Down 200; 11.6uM; HL60; HT_HG-U133A | NR2C1 CDS1 ZBTB17 INCENP SLC39A9 MRTFB PCDHGA10 SKP2 CAPN10 BICRAL | 2.32e-05 | 198 | 219 | 10 | 2182_DN |
| Drug | sorafenib | 2.32e-05 | 158 | 219 | 9 | CID000216239 | |
| Drug | MCNU | 2.33e-05 | 36 | 219 | 5 | CID000071741 | |
| Drug | A809128 | 2.33e-05 | 36 | 219 | 5 | CID003392279 | |
| Drug | pyran | 2.67e-05 | 37 | 219 | 5 | CID000033703 | |
| Drug | acyclovir | 2.73e-05 | 124 | 219 | 8 | CID000002022 | |
| Drug | anagrelide | 3.05e-05 | 38 | 219 | 5 | CID000002182 | |
| Drug | fotemustine | 3.05e-05 | 38 | 219 | 5 | CID000104799 | |
| Drug | isofagomine lactam | 3.47e-05 | 39 | 219 | 5 | CID000448980 | |
| Drug | AC1L1HZP | 3.48e-05 | 64 | 219 | 6 | CID000004361 | |
| Drug | adefovir | 3.48e-05 | 64 | 219 | 6 | CID000060172 | |
| Drug | amantadine | 3.73e-05 | 95 | 219 | 7 | CID000002130 | |
| Drug | Clorgyline | 3.77e-05 | 168 | 219 | 9 | ctd:D003010 | |
| Drug | copolymer 1 | 4.15e-05 | 66 | 219 | 6 | CID003081884 | |
| Drug | AC1LAD6M | 4.74e-05 | 8 | 219 | 3 | CID000511663 | |
| Drug | O4-[3-[(1S)-6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxyphenyl)-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] O1-[3-[(1R)-6,7-dimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] (Z)-2-chlorobut-2-enedioate | 4.74e-05 | 8 | 219 | 3 | CID010011375 | |
| Drug | 1 ind | 5.01e-05 | 42 | 219 | 5 | CID003037877 | |
| Drug | MeSAdo | 5.57e-05 | 137 | 219 | 8 | CID000000149 | |
| Drug | AC1NRBRB | 5.62e-05 | 43 | 219 | 5 | CID005288597 | |
| Drug | NSC 312887 | 5.62e-05 | 43 | 219 | 5 | CID000003368 | |
| Drug | Sesquimustard | 5.62e-05 | 43 | 219 | 5 | CID000019092 | |
| Drug | N6-methyl-(R)-roscovitine | 6.29e-05 | 71 | 219 | 6 | CID005289296 | |
| Drug | cryptolepine | 6.39e-05 | 23 | 219 | 4 | ctd:C024015 | |
| Drug | Telaprevir | 7.07e-05 | 9 | 219 | 3 | CID003010818 | |
| Drug | boceprevir | 7.07e-05 | 9 | 219 | 3 | CID010324367 | |
| Drug | AC1L9AL3 | 7.82e-05 | 46 | 219 | 5 | CID000441122 | |
| Drug | AC1L1GHH | 7.94e-05 | 74 | 219 | 6 | CID000003685 | |
| Drug | dideoxyinosine | 8.57e-05 | 75 | 219 | 6 | CID000003043 | |
| Drug | entecavir | 8.68e-05 | 47 | 219 | 5 | CID000153941 | |
| Drug | hydroxyurea | HDAC9 MCM5 MCM6 MCM7 NR2E3 POLE RECQL IFNA4 IFNA5 IFNA7 IFNA8 IFNA10 IFNA17 RPA2 | 9.02e-05 | 436 | 219 | 14 | CID000003657 |
| Drug | emtricitabine | 9.14e-05 | 147 | 219 | 8 | CID000060877 | |
| Drug | antiarol | 9.21e-05 | 2 | 219 | 2 | CID000069505 | |
| Drug | Uc39 | 9.21e-05 | 2 | 219 | 2 | CID003000889 | |
| Drug | thioflavone | 9.21e-05 | 2 | 219 | 2 | CID000069914 | |
| Drug | 1 Jak | 9.23e-05 | 76 | 219 | 6 | CID000446429 | |
| Drug | bromcresol green | 9.52e-05 | 110 | 219 | 7 | CID000006451 | |
| Drug | NSC289637 | 9.62e-05 | 48 | 219 | 5 | CID000004213 | |
| Drug | adefovir dipivoxil | 1.06e-04 | 49 | 219 | 5 | CID000060871 | |
| Drug | mu-I | 1.07e-04 | 78 | 219 | 6 | CID011987863 | |
| Drug | Glycocholic acid [475-31-0]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 1.14e-04 | 194 | 219 | 9 | 5316_DN | |
| Drug | neocarzinostatin chromophore | ABCA10 ABCA9 ABCA8 RYK ZHX2 CRH IFNA4 IFNA5 IFNA7 IFNA10 IFNA17 | 1.16e-04 | 288 | 219 | 11 | CID000447545 |
| Drug | TISCH | 1.29e-04 | 51 | 219 | 5 | CID000125486 | |
| Drug | DTIC | 1.32e-04 | 81 | 219 | 6 | CID005281007 | |
| Drug | catechin; Down 200; 11uM; MCF7; HT_HG-U133A_EA | 1.33e-04 | 198 | 219 | 9 | 1101_DN | |
| Drug | SC-57099B | 1.37e-04 | 11 | 219 | 3 | CID000178079 | |
| Drug | Cytosar-U | HDAC9 INCENP RYK NT5C1A POLE NT5C1B IFNA4 IFNA5 IFNA7 IFNA10 IFNA17 EGF RPA2 | 1.39e-04 | 399 | 219 | 13 | CID000000596 |
| Drug | plakin | 1.41e-04 | 82 | 219 | 6 | CID000018752 | |
| Disease | spinocerebellar ataxia type 5 (implicated_via_orthology) | 1.54e-06 | 4 | 216 | 3 | DOID:0050882 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | CLSTN3 ACACA SPTBN2 OTOP2 ABCA10 ABCA9 ABCA8 NLGN4X CCDC93 SYNE1 POLE HAT1 GRIN2A PTPRT CAPN10 CDH22 AKAP9 P2RX7 | 4.75e-06 | 702 | 216 | 18 | C0009402 |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 8.11e-05 | 12 | 216 | 3 | DOID:11726 (implicated_via_orthology) | |
| Disease | MYELODYSPLASTIC SYNDROME | 1.34e-04 | 67 | 216 | 5 | C3463824 | |
| Disease | hematological measurement, pulmonary function measurement, blood pressure, grip strength measurement, lipoprotein measurement, vital capacity | 1.59e-04 | 3 | 216 | 2 | EFO_0003892, EFO_0004312, EFO_0004325, EFO_0004503, EFO_0004732, EFO_0006941 | |
| Disease | lung small cell carcinoma (is_marker_for) | 2.02e-04 | 16 | 216 | 3 | DOID:5409 (is_marker_for) | |
| Disease | pulse pressure measurement | HDAC9 MYO1E LIN54 FAM186B RYK FCSK FASN ULK4 CRISPLD1 FAT3 NBEA MEI1 FAF1 FMNL3 SPTBN4 ULK3 SLIT1 SORCS3 UBR3 ACCSL PBX3 CHMP1A NIN | 2.42e-04 | 1392 | 216 | 23 | EFO_0005763 |
| Disease | complement C1r subcomponent-like protein measurement | 3.17e-04 | 4 | 216 | 2 | EFO_0801495 | |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 3.17e-04 | 4 | 216 | 2 | cv:CN293514 | |
| Disease | descending aortic diameter | 4.80e-04 | 88 | 216 | 5 | EFO_0021788 | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 5.26e-04 | 5 | 216 | 2 | C1450051 | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 5.26e-04 | 5 | 216 | 2 | C0410190 | |
| Disease | muscular disease (implicated_via_orthology) | 5.26e-04 | 5 | 216 | 2 | DOID:0080000 (implicated_via_orthology) | |
| Disease | airway responsiveness measurement | 6.99e-04 | 24 | 216 | 3 | EFO_0006897 | |
| Disease | Diffuse Large B-Cell Lymphoma | 7.11e-04 | 55 | 216 | 4 | C0079744 | |
| Disease | Autistic Disorder | 7.15e-04 | 261 | 216 | 8 | C0004352 | |
| Disease | forced expiratory volume | HDAC9 SPTBN2 PSMB3 TRIP11 ZBTB24 CROCC2 BMP8A CARNS1 IPO8 SYNE1 GRIN2A ZHX2 FAF1 CEP72 ANKFN1 | 7.58e-04 | 789 | 216 | 15 | EFO_0004314 |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 7.70e-04 | 264 | 216 | 8 | EFO_0008317, EFO_0020944 | |
| Disease | Emery-Dreifuss muscular dystrophy | 7.85e-04 | 6 | 216 | 2 | cv:C0410189 | |
| Disease | low density lipoprotein cholesterol measurement, body mass index | 7.85e-04 | 6 | 216 | 2 | EFO_0004340, EFO_0004611 | |
| Disease | Ischemic stroke, large artery stroke | 7.85e-04 | 6 | 216 | 2 | EFO_0005524, HP_0002140 | |
| Disease | Dysthymic Disorder | 7.85e-04 | 6 | 216 | 2 | C0013415 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 7.85e-04 | 6 | 216 | 2 | C0410189 | |
| Disease | non-high density lipoprotein cholesterol measurement | NHLRC2 ABCA9 PTPN3 HOOK1 SYNE2 POC1B BAIAP2L2 NR1H4 KPNB1 DNAH10 ULK3 FRK MAP4K5 DOCK7 | 8.33e-04 | 713 | 216 | 14 | EFO_0005689 |
| Disease | mean reticulocyte volume | HDAC9 MYH9 EZH2 TBC1D16 HOOK1 AFDN CARNS1 GOLGB1 DNAH2 ZHX2 SKP2 FAF1 MIPOL1 MAP4K5 CHMP1A | 8.61e-04 | 799 | 216 | 15 | EFO_0010701 |
| Disease | Hallux valgus | 9.88e-04 | 60 | 216 | 4 | HP_0001822 | |
| Disease | unipolar depression, bipolar disorder | 1.05e-03 | 156 | 216 | 6 | EFO_0003761, MONDO_0004985 | |
| Disease | Pilomyxoid astrocytoma | 1.09e-03 | 7 | 216 | 2 | C1519086 | |
| Disease | neuropilin-1 measurement | 1.09e-03 | 7 | 216 | 2 | EFO_0020603 | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 1.09e-03 | 7 | 216 | 2 | C0751337 | |
| Disease | mammographic density percentage | 1.23e-03 | 29 | 216 | 3 | EFO_0006502 | |
| Disease | lysophosphatidylethanolamine 20:4 measurement | 1.23e-03 | 29 | 216 | 3 | EFO_0010370 | |
| Disease | Hematopoetic Myelodysplasia | 1.23e-03 | 29 | 216 | 3 | C2713368 | |
| Disease | non-alcoholic fatty liver disease (biomarker_via_orthology) | 1.33e-03 | 65 | 216 | 4 | DOID:0080208 (biomarker_via_orthology) | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.43e-03 | 291 | 216 | 8 | EFO_0008317, EFO_0020946 | |
| Disease | disease recurrence, malaria | 1.45e-03 | 8 | 216 | 2 | EFO_0001068, EFO_0004952 | |
| Disease | fasting blood insulin measurement | 1.66e-03 | 69 | 216 | 4 | EFO_0004466 | |
| Disease | Polydactyly | 1.73e-03 | 117 | 216 | 5 | C0152427 | |
| Disease | Leukemia, Myelocytic, Acute | 1.78e-03 | 173 | 216 | 6 | C0023467 | |
| Disease | Intellectual Disability | 1.79e-03 | 447 | 216 | 10 | C3714756 | |
| Disease | free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 1.85e-03 | 303 | 216 | 8 | EFO_0004612, EFO_0020945 | |
| Disease | glioblastoma (implicated_via_orthology) | 1.86e-03 | 9 | 216 | 2 | DOID:3068 (implicated_via_orthology) | |
| Disease | corneal resistance factor | OTOP2 CENPK ABCA10 ABCA9 ABCA8 COL24A1 GOLGB1 PCED1A MIPOL1 TJP1 | 1.91e-03 | 451 | 216 | 10 | EFO_0010067 |
| Disease | Spinocerebellar Ataxia Type 2 | 1.96e-03 | 34 | 216 | 3 | C0752121 | |
| Disease | Spinocerebellar Ataxia Type 1 | 1.96e-03 | 34 | 216 | 3 | C0752120 | |
| Disease | Spinocerebellar Ataxia Type 5 | 1.96e-03 | 34 | 216 | 3 | C0752123 | |
| Disease | Spinocerebellar Ataxia Type 7 | 1.96e-03 | 34 | 216 | 3 | C0752125 | |
| Disease | Spinocerebellar Ataxia Type 6 (disorder) | 1.96e-03 | 34 | 216 | 3 | C0752124 | |
| Disease | Ataxia, Spinocerebellar | 1.96e-03 | 34 | 216 | 3 | C0087012 | |
| Disease | Spinocerebellar Ataxia Type 4 | 2.13e-03 | 35 | 216 | 3 | C0752122 | |
| Disease | lung cancer (is_implicated_in) | 2.15e-03 | 74 | 216 | 4 | DOID:1324 (is_implicated_in) | |
| Disease | leptin measurement, sex interaction measurement | 2.31e-03 | 10 | 216 | 2 | EFO_0005000, EFO_0008343 | |
| Disease | interleukin 4 measurement | 2.31e-03 | 36 | 216 | 3 | EFO_0008184 | |
| Disease | Malignant neoplasm of breast | CDS1 MYH9 CENPF EZH2 FASN HOOK1 SRGAP3 SYNE2 SLC10A6 DNAH9 GOLGB1 SYNE1 RECQL EPG5 EGF AKAP9 FLACC1 | 2.48e-03 | 1074 | 216 | 17 | C0006142 |
| Disease | response to risperidone | 2.70e-03 | 38 | 216 | 3 | GO_0097336 | |
| Disease | Mental Depression | 2.78e-03 | 254 | 216 | 7 | C0011570 | |
| Disease | level of Ceramide (d40:1) in blood serum | 2.81e-03 | 11 | 216 | 2 | OBA_2045185 | |
| Disease | sphingolipid measurement | 3.13e-03 | 40 | 216 | 3 | EFO_0004622 | |
| Disease | tumor protein p53-inducible protein 11 measurement | 3.35e-03 | 12 | 216 | 2 | EFO_0802169 | |
| Disease | high grade glioma (is_implicated_in) | 3.60e-03 | 42 | 216 | 3 | DOID:3070 (is_implicated_in) | |
| Disease | beta-nerve growth factor measurement | 3.60e-03 | 42 | 216 | 3 | EFO_0008035 | |
| Disease | autistic disorder (is_implicated_in) | 3.60e-03 | 42 | 216 | 3 | DOID:12849 (is_implicated_in) | |
| Disease | apolipoprotein B measurement | NHLRC2 ABCA10 ABCA9 ABCA8 HOOK1 SYNE2 CCDC93 KPNB1 DNAH10 FRK MAP4K5 DOCK7 | 3.74e-03 | 663 | 216 | 12 | EFO_0004615 |
| Disease | triglycerides in large LDL measurement | 3.85e-03 | 43 | 216 | 3 | EFO_0022319 | |
| Disease | apolipoprotein E measurement | 3.95e-03 | 13 | 216 | 2 | EFO_0008029 | |
| Disease | gallbladder cancer (is_implicated_in) | 3.95e-03 | 13 | 216 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | cholesterol in medium VLDL measurement | 4.11e-03 | 44 | 216 | 3 | EFO_0022225 | |
| Disease | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | 4.22e-03 | 206 | 216 | 6 | EFO_0004612, EFO_0020947 | |
| Disease | amino acid measurement | MYO1E COL24A1 CLU MYLK4 ULK4 MTUS2 SYNE1 ZNF596 DNAH7 MAP4K5 SLIT1 CCDC102B | 4.46e-03 | 678 | 216 | 12 | EFO_0005134 |
| Disease | Colorectal Neoplasms | 4.47e-03 | 277 | 216 | 7 | C0009404 | |
| Disease | cognitive function measurement | FAM186B BIRC6 ABCA8 NEDD9 TMEM245 MED12L SERPING1 VWA3B FBXO33 CCDC93 GPD2 NBEA GRIN2A PTPRT MIPOL1 FRK AP3B2 CNTNAP4 SORCS3 MYH15 | 4.50e-03 | 1434 | 216 | 20 | EFO_0008354 |
| Disease | Uterine leiomyoma | 4.54e-03 | 91 | 216 | 4 | HP_0000131 | |
| Disease | waist circumference | 4.56e-03 | 429 | 216 | 9 | EFO_0004342 | |
| Disease | alcohol use disorder (biomarker_via_orthology) | 4.58e-03 | 14 | 216 | 2 | DOID:1574 (biomarker_via_orthology) | |
| Disease | diet measurement | GABRB3 B3GALT1 HDAC9 TRIO MCM6 FAM186B NCEH1 FBXO33 PTPRT FRK CDH22 MAP4K5 SORCS3 UBR3 AKAP10 PBX3 | 4.71e-03 | 1049 | 216 | 16 | EFO_0008111 |
| Disease | free cholesterol in small VLDL measurement | 4.95e-03 | 47 | 216 | 3 | EFO_0022272 | |
| Disease | free cholesterol in very small VLDL measurement | 4.95e-03 | 47 | 216 | 3 | EFO_0022275 | |
| Disease | obesity (implicated_via_orthology) | 5.18e-03 | 215 | 216 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 5.33e-03 | 152 | 216 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Depressive disorder | 5.60e-03 | 289 | 216 | 7 | C0011581 | |
| Disease | mammographic density measurement | 5.89e-03 | 50 | 216 | 3 | EFO_0005941 | |
| Disease | omega-6:omega-3 polyunsaturated fatty acid ratio | 5.89e-03 | 50 | 216 | 3 | EFO_0010732 | |
| Disease | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement | 6.43e-03 | 225 | 216 | 6 | EFO_0008317, EFO_0010351 | |
| Disease | phospholipids in IDL measurement | 6.57e-03 | 52 | 216 | 3 | EFO_0022164 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 6.75e-03 | 17 | 216 | 2 | EFO_0004611, EFO_0007800 | |
| Disease | extrahepatic cholestasis (biomarker_via_orthology) | 6.75e-03 | 17 | 216 | 2 | DOID:13619 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LFDIVLMTNNHAQVG | 376 | Q96P26 | |
| LQQAMTEHFVQLTSR | 36 | Q4AC99 | |
| ITLDAQDVLAHLVQM | 711 | P55196 | |
| QLEAESHAAQLQILM | 251 | Q8NHY2 | |
| LMHQVESENLQQLSS | 726 | Q9HCE0 | |
| IAQQLHSTGEINIMQ | 1011 | P53355 | |
| MYENQSQVVLVENLH | 1641 | A6H8Y1 | |
| NQEESSQEVHMLSVA | 2191 | A6H8Y1 | |
| ETEFLSIHSQMTNLE | 1301 | Q99996 | |
| SIHSQMTNLEDIDVN | 1306 | Q99996 | |
| MQGQITDSNISEILH | 46 | Q8IY45 | |
| TQSHLVIQNLFEGMI | 226 | Q92903 | |
| SHAMASAEQQLQVLQ | 1621 | Q9NR09 | |
| SNEFIVEVNVLHSMN | 791 | Q9BQT9 | |
| LQFHALEENVMVASE | 151 | Q8NI51 | |
| ALQEMVHQVTDLSRN | 806 | Q14511 | |
| NAAIIEVTTNHSVME | 96 | Q8WWZ4 | |
| FDIVLMTNNHAQVGV | 121 | Q9BXI3 | |
| VLAQSIVFSAMEQEH | 341 | O43572 | |
| NAAIIEIATNHSVME | 186 | Q8IUA7 | |
| LMQSVLQFLQEHSEI | 1326 | Q7Z2Y8 | |
| VVNTESNVLMFQFEH | 671 | Q5XX13 | |
| LNQMVEQESQIFHDI | 126 | Q9Y5Z6 | |
| VELIVINDHQLFEQM | 241 | O75078 | |
| INDHQLFEQMRQSVV | 246 | O75078 | |
| ASMEQLQATINRAEH | 661 | Q9C0A0 | |
| ASQLVQTFIHFDMTE | 431 | A5YM72 | |
| RHNQVESIFLSAIDM | 1096 | Q13085 | |
| QSLSNHLFEELAMDV | 271 | Q14161 | |
| IHSQEMLGQFLQEVS | 651 | Q9HC96 | |
| IQELTQMLQESHSSL | 581 | Q9P209 | |
| ELSSQRLHFQQFMEV | 271 | Q8IYM0 | |
| SLQEMINFHTILFDQ | 86 | Q15057 | |
| AQQEITVQQLMAHLD | 106 | Q9GZT6 | |
| SEITNHRNMLLQTFE | 81 | P0C7W6 | |
| TSFLQNILQMHRDEE | 371 | Q5JU67 | |
| AIGISNFNHLQVEMI | 156 | P15121 | |
| HSEVQYVVLQNVATM | 351 | Q13367 | |
| SMENTLDVIEHLANN | 756 | Q9UFE4 | |
| QEFHQELVETMRGLQ | 251 | Q9UKD1 | |
| LEMENNHTVAITILQ | 1146 | Q5JR59 | |
| MATIEEIAHQIIEQQ | 1 | P13056 | |
| HVEALQDQSQVMLSQ | 341 | Q9Y5X4 | |
| QAESREHIVAFNMLN | 276 | P26045 | |
| ENFLILTEMATNHVQ | 296 | Q96RI1 | |
| LTEMATNHVQVLVEF | 301 | Q96RI1 | |
| DHLFETISQAMLNAV | 161 | P49720 | |
| EQQVQNLDVHTSVME | 116 | Q9HD42 | |
| HQIMTITDQSLDEAQ | 51 | P40426 | |
| MVAFTLELQHALQAI | 796 | Q8IY17 | |
| AISVLHEMIQQTFNL | 76 | P01566 | |
| VAIHEAMEQQTISIT | 471 | Q14566 | |
| LNLNELHETSMEQLF | 586 | Q8IVH8 | |
| VLESINVQMDENTLH | 651 | P43304 | |
| LMHLADAAEVRVQQQ | 641 | Q6MZP7 | |
| VDMHTNNELFTTVLD | 1556 | Q86YW9 | |
| QHQALLEAMEQQSIS | 526 | Q9UJA3 | |
| ELTAIIEQMNRDHQS | 136 | Q96Q35 | |
| RQNAEQHVTQLMSTE | 176 | Q9NQS7 | |
| LSDFLQAMEHTEVLQ | 106 | Q9UDY8 | |
| VAIHEAMEQQTISIA | 456 | P33992 | |
| MELQLQHAREASQVA | 401 | Q8TD10 | |
| NEIIHLMQQEETNLS | 401 | Q5VYY2 | |
| QDQVSIQSLHMVSEV | 216 | Q8IYT1 | |
| RDSVQEIAEMLSQHQ | 486 | Q8IYD8 | |
| NHSITQFTQADIDDM | 1716 | Q5SZK8 | |
| AISVLHEMIQQTFNL | 76 | P01568 | |
| VQMSDTQRHLNSDLE | 76 | Q6UXY1 | |
| VANTMEHLSLLDNNI | 276 | Q7Z6M2 | |
| LQQNFMVEDETVLHN | 116 | Q15910 | |
| SEQHYQMQLQDLETV | 86 | Q8N1A0 | |
| LSTEAHFMLQVADIN | 436 | Q9Y5H3 | |
| MNVFHVVVVIQDIND | 111 | Q9Y5G3 | |
| SDMVHFQASEVQQLL | 16 | Q9H1Q7 | |
| DFVQAMIVNNHTSLD | 261 | Q6PIU2 | |
| MIVNNHTSLDVEEAA | 266 | Q6PIU2 | |
| AISVLHEMIQQTFNL | 76 | P01569 | |
| AISVLHEMIQQTFNL | 76 | P01567 | |
| ISNAHSQQMDDLFDI | 891 | Q9ULH7 | |
| EISVMNQLDHANLIQ | 151 | Q86YV6 | |
| NILLTSLEVHNEMNE | 366 | P28472 | |
| LQQLFNHTMFILEQE | 476 | P35579 | |
| DFALTIHTQVFMEQI | 2241 | Q07864 | |
| ALEHIMEQLNVLTQT | 431 | Q8TC44 | |
| VLEMARAEQLAQQAH | 171 | P06850 | |
| NENMEITSALQSEQH | 561 | Q08379 | |
| QFLQMHEEAEAVLAT | 1681 | Q6R327 | |
| IMNNIIYVADTENHL | 286 | Q8NBF2 | |
| TAIHEVMEQQTISIA | 456 | P33993 | |
| GSLQVHQTLSVEMDQ | 1026 | Q5TIA1 | |
| AESILQFVHMVRQQA | 1111 | Q16827 | |
| EMIQQQNIIDVFHIV | 1396 | O14522 | |
| IAQHTFQNMFIIESL | 411 | Q7RTS6 | |
| NTTNDITHIQNEEIM | 716 | Q8NFZ3 | |
| SLFQDVTDAMNNIHQ | 166 | Q86YG4 | |
| VSFVDESHIRMVNQQ | 401 | Q99572 | |
| VMSAQHFVSTEQVEL | 686 | Q8N0W3 | |
| IHLTQQVDMAAQVAS | 326 | P42685 | |
| ISLLNSIHENFSQAM | 536 | Q567U6 | |
| NLETAMEVQSSVDHQ | 531 | P46100 | |
| QEAERVTLIQMTHFL | 481 | Q8WWV6 | |
| MSFHQNLQDVTEDQL | 141 | A0AVF1 | |
| ISMQHEQLEESFQEL | 391 | O14929 | |
| QLISGQVASEHVMLN | 431 | Q6AI39 | |
| QVQDLVFNLHMILSD | 1641 | Q96N67 | |
| EQMHQSFVAETSQRI | 871 | P49454 | |
| VSEDNITESQHMLVA | 811 | P01133 | |
| QHEVISENMASQIIV | 86 | Q96RU3 | |
| MNHISDILNVAFTII | 1146 | Q13698 | |
| EMEQAHTQRLQDLTA | 1566 | H7BZ55 | |
| AITDNDMQSILDLHN | 56 | Q9H336 | |
| QELFSSHVMQEESAN | 26 | Q5JV73 | |
| FINIVVHSVEDMNFR | 326 | Q8IVF7 | |
| EQQQIMESLNVLHSE | 131 | Q9BS16 | |
| NIQESSVNLITLHEM | 201 | Q9BS16 | |
| FNETDLRISVQQLHM | 3606 | Q8WXX0 | |
| VHEMLQNTVTIRFEN | 3641 | Q8TDW7 | |
| SEHVIMQNEALVALA | 501 | P52306 | |
| LHVSMFQVVQEQSNR | 161 | Q7Z5Y6 | |
| VQLINTVLNGDQHFM | 351 | Q13617 | |
| AVNFAMHELQLIRVE | 201 | Q8J025 | |
| LQVSAMQHQTVLELT | 436 | P05155 | |
| MQHQTVLELTETGVE | 441 | P05155 | |
| QHQDALQISDVVMAS | 596 | Q14974 | |
| NIVVHSVENMNFRVF | 331 | O95466 | |
| LSLSQQDGIEQHMDF | 206 | Q8IWT3 | |
| AISVLHEMIQQTFNL | 76 | P32881 | |
| ESQEEMLQVFNVETH | 1491 | Q9H583 | |
| NITVLAMEADNHAQL | 466 | Q9UJ99 | |
| HQIIVQNVTMDEETA | 686 | Q66K89 | |
| LVEALENHNEVNTVM | 2781 | Q9NYC9 | |
| ENHNEVNTVMDLVLF | 2786 | Q9NYC9 | |
| LQESLNQNFMLIITH | 186 | Q9UNN5 | |
| EHIQNIMTLEESVQH | 136 | Q9UJC3 | |
| EQMVSQQRILIHEDS | 301 | Q9UKV0 | |
| FVQQFTDMEHNRVLE | 2371 | P49327 | |
| LHVSMFQVVQEQSNR | 161 | P34820 | |
| HSIQLIRDEFLMNVQ | 191 | Q8IVF4 | |
| VHTYQQMVQAIDELV | 581 | Q9P225 | |
| ASIDREIAMHNQQLS | 516 | Q9H4Q3 | |
| HTQLEQMFRDIATIV | 101 | Q9Y3A5 | |
| QTSVQLIVFVAIMLH | 171 | Q9NUM3 | |
| AISQQDLVHMAIQIA | 436 | P34925 | |
| TDQFQLSSQMHESIR | 171 | Q68D86 | |
| NTTNDIAHIQNEEIM | 716 | Q8N0W4 | |
| AISVLHEMIQQTFNL | 76 | P01571 | |
| MILLIQDDAVHTLQF | 251 | Q03701 | |
| IIHVDQIVQMASQLF | 1161 | P46019 | |
| LNLNELHEATMEQLF | 536 | Q9Y4K4 | |
| SQEVASIAVDMTQHL | 571 | O15397 | |
| MVDHLANTEINSQRI | 1 | Q96S99 | |
| TVFSSQLQVHMVLQL | 241 | Q6P087 | |
| FNDLVSSAHMLQVNR | 891 | A5PLK6 | |
| LQSIFQEQGMAESVH | 26 | P52788 | |
| STFLELLHMEIDNSQ | 166 | Q9ULQ0 | |
| VQKETQFHTELMAQA | 6656 | Q8NF91 | |
| LTEMDLQLTNVEHFS | 6261 | Q8WXH0 | |
| MSLQILNTHITELNE | 56 | Q8TF66 | |
| VSQMNSLEQELETIH | 1926 | Q8N4C6 | |
| MHIISTDENQVFAAV | 436 | Q9UPU3 | |
| TEALHQNMQALFSTL | 216 | Q5VZ19 | |
| QDMLHNRENQSILFT | 181 | Q9Y2K3 | |
| VMDFVNSNENIIFVH | 1366 | Q8NFP9 | |
| QFDQDHNINLVSMEV | 1311 | Q13017 | |
| HNINLVSMEVTVNAV | 1316 | Q13017 | |
| AISVLHEMIQQTFNL | 76 | P05014 | |
| QIASFHMDTVVVNLL | 1076 | Q7Z745 | |
| MEQHNLTTVNEFILT | 1 | Q8NH51 | |
| NIQVLHSVFDQSAEM | 236 | Q9BWV2 | |
| SQILSDREEIAHNMQ | 161 | P27105 | |
| QNTVETLQRMHTTFE | 1836 | Q01082 | |
| SNFEDMLLTIIHIIQ | 1091 | O94911 | |
| AMHLNTLVQEAQERV | 211 | Q8N957 | |
| STEFMHQIIDQVLQG | 376 | Q96JQ2 | |
| MVTFDSAAHVQNELI | 346 | A8K7I4 | |
| SEMTFREQTSHQIIQ | 71 | Q8N8G6 | |
| SLLENDRQQTHMLDV | 161 | P10909 | |
| LNMSDNITQHDDRVT | 371 | Q17RW2 | |
| TELTQSQMLHIAQQI | 646 | Q16620 | |
| TAMLHDFTQQVQVIE | 726 | P48736 | |
| ANLLNNEAHAITMQV | 576 | P46063 | |
| FRVQHMDLSNSVIEV | 181 | Q13309 | |
| QQQMAVLEHLQASVT | 81 | Q96A04 | |
| NIQHFLEDETVATVM | 1296 | A0JNW5 | |
| MHNLLETDIEQVSQL | 201 | Q99961 | |
| LFQDVMLENISHLVS | 31 | Q8TC21 | |
| DMNEFTTHILEVINA | 151 | P15927 | |
| AQTIHQLAASSQDMI | 1641 | O15020 | |
| RDHATLNDIFMNNVI | 111 | O43295 | |
| IHVLISDEMIQNFQE | 466 | Q12800 | |
| ITTVENFQHFMDRIS | 151 | Q9GZZ9 | |
| QVEQMLAHLTSASAQ | 1226 | Q5XPI4 | |
| AQLQEEAFMSQVHSV | 321 | Q8IV04 | |
| VIEQQLATDQMLLHF | 656 | Q8TBP0 | |
| ISAAKQEINSHVEMQ | 166 | P05543 | |
| IHSRIDEMSQDILQQ | 146 | Q8IZ13 | |
| ITMLQLSFTAEHLVQ | 271 | Q3KNW5 | |
| QMLEVHQFAQEAVVA | 2046 | Q9H254 | |
| ISFQNEQVLQETEMH | 66 | A0A0A0MS06 | |
| ADMTNFDVEVLLNIH | 261 | Q9BV44 | |
| QEQTEHIQSLNMIES | 611 | O43167 | |
| DELRHQVMINQFVLA | 6 | Q8IYN6 | |
| VSMDNVEHAFAVQQL | 81 | Q07157 | |
| TAMELEFQAHVVNEI | 181 | Q401N2 | |
| STQNLNEFTEHVDMQ | 86 | Q9Y6X8 | |
| QESVHMIEVTSNLIN | 486 | Q9H330 | |
| VSSHISQAIIQMIVE | 406 | P86452 | |
| DANEQMVLAHVTNRL | 306 | Q6NXT4 | |
| VRIHTAQALVMFQTD | 736 | Q13105 | |
| LSLANLQMVLEHFQQ | 1671 | Q15643 | |
| LLTMASQHQNTVLDA | 741 | Q6ZT12 | |
| MLVHVDNEASINQTT | 61 | O75971 | |
| LQQINSMVDFLEVVH | 1201 | A6NGW2 | |
| SEIAFLQMSDLTVHQ | 246 | P17014 | |
| EMLQQVTQLEAAEHL | 306 | O15482 | |
| MQLFVRAQELHTFEV | 1 | P62861 | |
| EALTMVLQEQVAHIT | 161 | Q502W6 | |
| SSMAVHLLQAQEDLA | 461 | P0DP72 | |
| FHTVELVAFDQMVNL | 1246 | O75093 | |
| QHLFLLQDENMVSFI | 171 | Q5SRH9 | |
| EISELSHNFVMVNLE | 81 | O95881 | |
| AERLIFSHAVQMVQS | 976 | O75385 | |
| EEHMQLSFTNVVRQS | 1226 | Q14202 | |
| SELDNMFVHLTNVAI | 231 | O95922 | |
| LTMNNLTFDVIHQGQ | 836 | O75962 | |
| HFQVTLNDIQLQMEQ | 276 | P40222 | |
| EHQESILGNTMQSVI | 1041 | Q96C45 | |
| VFMQQLASALQFLHE | 116 | Q6PHR2 | |
| QLQDAQILHSMAIDS | 111 | Q6IPR3 | |
| LQQMEAEHNTLRNTV | 296 | Q14789 | |
| TLQENLENLMDIHVF | 981 | O75096 | |
| SLEHLDLNNNAIMSI | 411 | O94898 | |
| AIMSIQENAFSQTHL | 421 | O94898 | |
| LHLLQSVNMDSDQFQ | 656 | Q12965 | |
| QEAVAQMLDFISSHT | 106 | Q12879 |